{"text": "A clinical trial has demonstrated that HIV - infected adults in a resource - limited setting are more likely to survive if they start antiretroviral therapy ( ART ) before their immune systems are severely compromised .", "label": "", "metadata": {}, "score": "25.401123"}
{"text": "However , the point during the course of HIV infection at which antiretroviral therapy ( ART ) is best initiated in asymptomatic patients remains unclear .", "label": "", "metadata": {}, "score": "25.967007"}
{"text": "Numerous clinical trials as well as observational data ( i.e. studies from clinical practice ) have demonstrated beyond reasonable doubt that the benefits of antiretroviral treatment for people with HIV / AIDS far outweigh their risks .", "label": "", "metadata": {}, "score": "31.370075"}
{"text": "Objective : Few data describe antiretroviral treatment ( ART)-related adverse events when treatment is initiated at CD4 + cell counts more than 350 cells / \u03bcl .", "label": "", "metadata": {}, "score": "33.305305"}
{"text": "Read more \" . ... for continuing studies to examine the risks and benefits of starting antiretroviral therapy , or ART , for patients with high CD4 cell count s , \" HealthDay News reports .", "label": "", "metadata": {}, "score": "35.37117"}
{"text": "Introduction .The impact of antiretroviral therapy ( ART ) on viral transmission [ 1 ] and pragmatic programmatic recommendations have led to several HIV treatment guidelines committees now recommending ART at CD4 + cell counts more than 350 cells / \u03bcl [ 2 - 4 ] .", "label": "", "metadata": {}, "score": "38.39781"}
{"text": "However , this needs consideration in the broader context of issues such as potential toxicity ( particularly first - trimester ART exposure ) , adherence , drug resistance , obstetric outcomes , and women 's views and preferences .", "label": "", "metadata": {}, "score": "40.876236"}
{"text": "Potential means to reduce this burden of TB might include initiation of ART at higher CD4 cell counts [ 17 ] and use of the interventions included within the World Health Organization ( WHO ) ' 3Is policy ' [ 18 ] .", "label": "", "metadata": {}, "score": "41.069874"}
{"text": "In conclusion , low baseline CD4 cell counts and ' unmasking ' of subclinical TB are likely to explain the high burden of TB during the first 4 months of ART .", "label": "", "metadata": {}, "score": "41.550087"}
{"text": "The recommended initial ART regimen included two nucleoside reverse transcriptase inhibitors ( NRTIs ) and one non - NRTI ( NNRTI ) inhibitor [ 35 ] .", "label": "", "metadata": {}, "score": "42.671425"}
{"text": "While the authors concluded that these differences were quite small and probably did not justify the added expense of CD4 cell count testing , they were unable to show that clinical monitoring was not inferior to CD4 cell count monitoring .", "label": "", "metadata": {}, "score": "42.760025"}
{"text": "A possible explanation for the increased rate of liver - related LDAE is that HIV seroconverters may be overrepresented in the group initiating ART with a CD4 + cell count at least 500 cells / \u03bcl when elevated transaminases is common [ 19,20 ] .", "label": "", "metadata": {}, "score": "42.79792"}
{"text": "Reduced laboratory monitoring , however , might also lead to premature or delayed changes to second line treatment , more antiretroviral resistance , or increased morbidity .", "label": "", "metadata": {}, "score": "43.397728"}
{"text": "When a patient 's cell count reaches 200 cells/ \u03bcL , however , the immune system is severely weakened and ART is necessary .A patient with advanced symptoms receives treatment regardless of CD4 count .", "label": "", "metadata": {}, "score": "43.74723"}
{"text": "Clinical trials for specific antiretroviral medicines .This list of clinical trials demonstrating the efficacy of specific antiretrovirals is incomplete .Currently , we neither list all the available antiretrovirals nor , in some cases , all the phase III trials for a particular antiretroviral .", "label": "", "metadata": {}, "score": "43.786697"}
{"text": "How TB risk changes over time in association with immune recovery in the short - term and long - term has not been clearly defined .", "label": "", "metadata": {}, "score": "44.18615"}
{"text": "Furthermore , we report low mortality and high retention for all patients initiating ART .These findings are particularly important as national PMTCT programs evolve to prioritize the identification and treatment of eligible pregnant women with therapeutic ART [ 25 ] .", "label": "", "metadata": {}, "score": "44.522022"}
{"text": "Further , there may have been biological differences such as viral subtype , host factors , or underlying opportunistic infection rates that may have influenced the CD4 + cell response rate .", "label": "", "metadata": {}, "score": "44.650406"}
{"text": "[PubMed ] .Tuboi SH , Brinkhof MW , Egger M , Stone RA , Braitstein P , Nash D , et al .Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource - constrained countries : the antiretroviral therapy in low - income countries ( ART - LINC ) collaboration .", "label": "", "metadata": {}, "score": "45.026466"}
{"text": "However , there are few data demonstrating the success of these programs , particularly on virological response - a crucial outcome to predict drug resistance and long - term program sustainability .", "label": "", "metadata": {}, "score": "45.45278"}
{"text": "Introduction .By the end of 2007 , it is estimated that more than three million adults and children were reported to have initiated antiretroviral therapy ( ART ) in low and middle - income countries [ 1 ] .", "label": "", "metadata": {}, "score": "45.56311"}
{"text": "These results provide reassurance to clinicians and patients in resource limited settings who have access to CD4 cell counts but not viral load testing .Most people taking ART in Africa , however , receive limited laboratory monitoring .", "label": "", "metadata": {}, "score": "45.576477"}
{"text": "Although this is an effective prevention measure [ 3 - 5 ] , increased morbidity and mortality among people randomized to scheduled HIV treatment interruptions have been reported in non - pregnant populations [ 6,7 ] , which may have implications for optimal management of HIV in childbearing women .", "label": "", "metadata": {}, "score": "46.004208"}
{"text": "Most people in the clinical monitoring arm with virological failure had detectable virus and worsening adherence three to six months later .In addition , CD4 cell count predicts risk for clinical events , even with undetectable virus .", "label": "", "metadata": {}, "score": "46.01606"}
{"text": "The objective of this review is to assess the evidence for the optimal time to initiate ART in HIV - infected adults who have not previously received therapy and who do not have symptoms of HIV illness .", "label": "", "metadata": {}, "score": "46.23944"}
{"text": "Evidence from clinical trials .Meta - analysis of antiretroviral trials .Siegfried , Uthman & Rutherford ( 2010 )Optimal time for initiation of antiretroviral therapy in asymptomatic , HIV - infected , treatment - naive adults ( Review ) .", "label": "", "metadata": {}, "score": "46.376305"}
{"text": "Although all person - time accrued during TB treatment was excluded from the analysis , a similar protective effect may also have been present during the period following TB treatment in the many patients with TB diagnoses at baseline .", "label": "", "metadata": {}, "score": "46.597115"}
{"text": "Thus , our results suggest that the CD4 + cell count response to ART initiated during pregnancy is similar to the response of other nonpregnant adults .", "label": "", "metadata": {}, "score": "46.615967"}
{"text": "Participants who met clinical or laboratory definitions of failure of ART were generally switched to didanosine , tenofovir , and lopinavir / ritonavir .For the CD4 monitoring arm , persistently declining CD4 cell counts on two consecutive measurements was considered to indicate treatment failure .", "label": "", "metadata": {}, "score": "46.7586"}
{"text": "This review explains that four AZT versus placebo trials have demonstrated that AZT significantly reduces the risk of mother - to - child transmission of HIV .", "label": "", "metadata": {}, "score": "46.849663"}
{"text": "The analysis of CD4 + cell count response was restricted to patients with a ' baseline ' CD4 + cell count measure ( up to 13 weeks before or 4 weeks after ART initiation ) and at least one follow - up measurement .", "label": "", "metadata": {}, "score": "46.891674"}
{"text": "Well designed cohort studies have also shown morbidity and mortality benefits of ART at CD4 + cell counts more than 350 cells / \u03bcl with these effects appearing enhanced in the presence of comorbidities , coinfections and advancing age [ 9,10 ] .", "label": "", "metadata": {}, "score": "47.098305"}
{"text": "However , in comparison with well resourced settings , high early mortality rates during the first few months of treatment are likely due to ART initiation at an advanced stage of HIV disease .", "label": "", "metadata": {}, "score": "47.488724"}
{"text": "Although the ART scale - up has progressed rapidly over the last several years , PMTCT programs have lagged behind with limited coverage and a dependence on single - dose nevirapine ( SD - NVP ) [ 1,24,25 ] .", "label": "", "metadata": {}, "score": "47.575603"}
{"text": "The first response to a worsening trend in CD4 or viral load was counselling about adherence to treatment .Supplemental CD4 and viral load assessments could be ordered during clinic visits .", "label": "", "metadata": {}, "score": "47.631706"}
{"text": "Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States .", "label": "", "metadata": {}, "score": "47.672256"}
{"text": "Several lines of indirect evidence support our hypothesis .First , high rates of subclinical , culture - proven TB have been detected in patients enrolling for ART in this [ 32 ] and in other HIV cohorts in Africa [ 33 - 36 ] .", "label": "", "metadata": {}, "score": "47.90889"}
{"text": "Art .No . : CD008272 .DOI:10.1002/14651858 .CD008272.pub2 .PLAIN LANGUAGE SUMMARY When is the best time to start antiretroviral therapy in people with HIV infection , who have not received antiretroviral treatment before and who do not have any symptoms of HIV illness ?", "label": "", "metadata": {}, "score": "48.03031"}
{"text": "In keeping with ' unmasking ' TB , excess rates were restricted to those with baseline CD4 cell counts less than 200 cells / \u03bcl and were confined to early ART [ 19,20,27,28 ] .", "label": "", "metadata": {}, "score": "48.045628"}
{"text": "TB prevention would be improved by ART policies that minimized the time patients spend with CD4 cell counts below a threshold of 500 cells / \u03bcl .", "label": "", "metadata": {}, "score": "48.07322"}
{"text": "These findings are similar to other studies [ 3,4,39,40 ] in Africa demonstrating good immunologic response to ART .The Antiretroviral Therapy in Lower Income Countries ( ART - LINC ) collaboration found a median CD4 + cell count rise from 108 to 442 cells / \u03bcl after 60 months of treatment [ 41 ] .", "label": "", "metadata": {}, "score": "48.077915"}
{"text": "A study showing improved survival of starting antiretroviral treatment earlier than current U.S. recommendations is being reported in the April 30 issue of the New England Journal of Medicine .", "label": "", "metadata": {}, "score": "48.22238"}
{"text": "One concern of earlier ART initiation is the assumed ambivalence of asymptomatic HIV - positive individuals who start ART with high CD4 + cell counts who may be less inclined to remain adherent to ART in the long term .", "label": "", "metadata": {}, "score": "48.222675"}
{"text": "To be included in each post - initiation time point , patients had to have a CD4 + cell count measurement recorded within \u00b16 weeks of that date .", "label": "", "metadata": {}, "score": "48.25729"}
{"text": "It is also salient that a quarter of women with CD4 + at least 350 cells / \u03bcl at their first pregnancy had fallen below the treatment threshold by their second pregnancy .", "label": "", "metadata": {}, "score": "48.315506"}
{"text": "Once entered into the study , half of the participants will be assigned randomly to receive immediate antiretroviral therapy .The other half of the study group will not receive antiretroviral therapy until their CD4 counts fall below 350 cells / mm\u00b3 or an AIDS - related event occurs .", "label": "", "metadata": {}, "score": "48.323235"}
{"text": "Further , these individuals were captured in the analysis of retention rates .In summary , we have demonstrated that pregnant women as well as nonpregnant women and male partners who initiated first - line ART had excellent CD4 + cell count response and high retention in care during the first 2.5 years of follow - up .", "label": "", "metadata": {}, "score": "48.36639"}
{"text": "Abstract .Objective : To determine the short - term and long - term risks of tuberculosis ( TB ) associated with CD4 cell recovery during antiretroviral therapy ( ART ) .", "label": "", "metadata": {}, "score": "48.43048"}
{"text": "Despite this , however , studies from within the region have reported that rates of TB during ART persist at levels much higher than background rates [ 7 - 11 ] .", "label": "", "metadata": {}, "score": "48.518074"}
{"text": "The authors conclude \" The initial drop in mortality and morbidity after the introduction of HAART has been sustained .Potential long - term adverse effects associated with HAART have not altered its effectiveness in treating AIDS . \"", "label": "", "metadata": {}, "score": "48.532387"}
{"text": "By the end of 2011 , 8 million people had started antiretroviral therapy ( ART ) worldwide ( 1 ) .The roll out of ART has added 15 million life - years in low- and middle - income countries , and it is estimated that it can reduce the HIV incidence by 17 - 32 % ( 1 , 2 ) .", "label": "", "metadata": {}, "score": "48.772003"}
{"text": "Pre - ART investigations for TB were routinely done only in those with suggestive symptoms or clinical signs .These data suggest the potential need for routine microbiological screening for TB at baseline in all patients starting ART in this setting and this approach is supported by the findings of a more recent study in this cohort [ 32 ] .", "label": "", "metadata": {}, "score": "48.90673"}
{"text": "Prior exposure to NVP has been demonstrated to reduce the likelihood of achieving viral suppression during subsequent treatment with an NNRTI - based regimen , particularly if started within 6 months of delivery [ 49 ] .", "label": "", "metadata": {}, "score": "49.255413"}
{"text": "( 2006 ) ( referred to above under AZT )This Cochrane review describes the evidence that single - dose nevirapine is effective at reducing mother - to - child transmission prevention .", "label": "", "metadata": {}, "score": "49.363197"}
{"text": "The current medical consensus is that treatment should still be deferred until a CD4 count of between 200 and 350 or an AIDS - defining illness occurs .", "label": "", "metadata": {}, "score": "49.722477"}
{"text": "ABSTRACT .Background According to consensus , initiation of therapy is best based on CD4 cell count , a marker of immune status , rather than on viral load , a marker of virologic replication .", "label": "", "metadata": {}, "score": "49.732178"}
{"text": "i m confused becuase most of the information i can ...Read more \" . ... for continuing studies to examine the risks and benefits of starting antiretroviral therapy , or ART , for patients with high CD4 cell count s , \" HealthDay News reports .", "label": "", "metadata": {}, "score": "49.834488"}
{"text": "Adjunctive TB prevention strategies such as the WHO ' 3Is policy ' [ 18 ] are also needed to reduce TB in ART services .Within this policy , intensified case finding ( ICF ) might be done not only at baseline but also serially ( e.g. 6-monthly ) during at least the first year of ART when TB rates are highest .", "label": "", "metadata": {}, "score": "50.072407"}
{"text": "We now know why taking AZT as a monotherapy before developing symptoms of AIDS was an unsuccessful strategy .Patients taking one antiretroviral develop a strain of HIV resistant to the virus in very short time ( a few months on average ) .", "label": "", "metadata": {}, "score": "50.078636"}
{"text": "Data from this study provide insight into the strategies needed to reduce the long - term burden of incident TB .Most fundamentally , the time that patients spend at low CD4 cell counts less than 500 cells / \u03bcl needs to be minimized .", "label": "", "metadata": {}, "score": "50.184776"}
{"text": "The individual risk of ART - related adverse events must be evaluated in the context of the potential benefits for that individual , considering comorbidities , age , sexual practices and long - term prognosis .", "label": "", "metadata": {}, "score": "50.53238"}
{"text": "While data from randomized clinical trials exist to support starting antiretroviral treatment when CD4 counts fall below 350 cells per cubic millimeter ( mm\u00b3 ) , well - designed clinical trials have not been conducted to guide decisions to support starting treatment above that threshold .", "label": "", "metadata": {}, "score": "50.601624"}
{"text": "Firstly , the indication for starting ART in those with a CD4 + cell count more than 350 cells / \u03bcl was not known .It is likely that many individuals starting ART with CD4 + cell counts at least 500 cells / \u03bcl did so due to the presence of comorbidities , which may independently cause laboratory abnormalities that would have been classified as LDAEs in our analyses .", "label": "", "metadata": {}, "score": "50.898872"}
{"text": "Excess tuberculosis rates during early antiretroviral therapy .Thus far we have demonstrated that TB rates during ART were very strongly associated with updated CD4 cell counts .", "label": "", "metadata": {}, "score": "51.0019"}
{"text": "Antiretroviral treatment of adult HIV infection : 2012 recommendations of the International Antiviral Society - USA panel .JAMA 2012 ;308:387 - 402 .Grinsztejn B , Hosseinipour MC , Swindells S , Ribaudo H , Eron J , Chen YQ , et al .", "label": "", "metadata": {}, "score": "51.007988"}
{"text": "Opportunistic infections occurred in 24 AZT recipients and 45 placebo recipients .ACTG 016 : AZT shown to be effective for symptomatic patients with CD4 of 200 - 500 .", "label": "", "metadata": {}, "score": "51.102932"}
{"text": "Egger M , May M , Chene G , Phillips AN , Ledergerber B , Dabis F , et al .Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy : a collaborative analysis of prospective studies .", "label": "", "metadata": {}, "score": "51.296394"}
{"text": "We also hypothesized that patients with the lowest baseline CD4 cell counts would accrue substantially more person - time within the lowest CD4 cell strata and thereby remain at high risk of TB for long periods .", "label": "", "metadata": {}, "score": "51.391724"}
{"text": "We present some of the evidence demonstrating that their benefits outweigh their risks here .The current standard of care for people with HIV indicated for treatment , is a combination of three or more antiretroviral drugs taken everyday for life , known as Highly Active Antiretroviral Treatment ( HAART ) .", "label": "", "metadata": {}, "score": "51.404243"}
{"text": "In multivariable analyses , women starting ART during pregnancy had 4.3-fold increased odds of detectable viral load adjusting for time period , region , ART type , and earliest CD4 + cell count , compared with women conceiving on ART ( Table 1 ) .", "label": "", "metadata": {}, "score": "51.791534"}
{"text": "Long - term ' ART was defined as treatment beyond 4 months .The terms ' updated CD4 cell count ' and ' updated viral load ' were used to refer to follow - up measurements during ART .", "label": "", "metadata": {}, "score": "52.04873"}
{"text": "Braitstein P , Brinkhof MW , Dabis F , Schechter M , Boulle A , Miotti P , et al .Mortality of HIV-1-infected patients in the first year of antiretroviral therapy : comparison between low - income and high - income countries .", "label": "", "metadata": {}, "score": "52.149384"}
{"text": "In multivariate analysis , baseline CD4 cell counts did not have any predictive value for TB risk over and above that provided by the current CD4 cell count at any given time - point .", "label": "", "metadata": {}, "score": "52.17277"}
{"text": "For analyses of the incidence of illnesses , we used a Poisson regression model with a log link function .Person time for people lost to follow - up or transferred to a different provider was censored at the time of the last home visit at which they received ART .", "label": "", "metadata": {}, "score": "52.20105"}
{"text": "The multiple lines of evidence for ' unmasking ' TB during early ART are indirect and yet provide a coherent and biologically plausible explanation .Baseline characteristics of the patients were typical of patients in ART roll - out programmes across Africa , but rates of loss to follow - up were comparatively low [ 44 ] .", "label": "", "metadata": {}, "score": "52.245846"}
{"text": "Importantly , however , patients with low baseline CD4 cell counts accrued much greater person - time within low CD4 cell strata , thereby remaining at high TB risk for longer periods .", "label": "", "metadata": {}, "score": "52.369965"}
{"text": "For more information , please refer to our Privacy Policy .Immunologic status and virologic outcomes in repeat pregnancies to HIV - positive women not on antiretroviral therapy at conception : a case for lifelong antiretroviral therapy ?", "label": "", "metadata": {}, "score": "52.555428"}
{"text": "Trial registration Clinical Trials NCT00119093 .Introduction .Access to antiretroviral therapy ( ART ) in Africa increased dramatically over the past decade , beginning with a few thousand people and reaching five million people by mid-2010 .", "label": "", "metadata": {}, "score": "52.595413"}
{"text": "3 ) .We next reasoned that the overall rate of TB in the cohort would be related to the proportions of person - time accrued at different CD4 cell count levels .", "label": "", "metadata": {}, "score": "52.624893"}
{"text": "Treatment compliance was high with over 90 % of patients achieving viral load suppression less than 400 copies / ml [ 22 ] and with a virological failure rate of approximately 2 % of patients per year [ 24 ] .", "label": "", "metadata": {}, "score": "52.733887"}
{"text": "In contrast , within the 201 - 300 cells / \u03bcl CD4 cell stratum , rates in two periods did not significantly differ .This excess TB incidence rate observed during early ART among those with CD4 cell counts 0 - 200 cells / \u03bcl was found to be confined to the first 4 months of treatment .", "label": "", "metadata": {}, "score": "52.749557"}
{"text": "Some TB disease may have remained unascertained among those who died , leading to underestimation of TB rates particularly in those with the lowest CD4 cell counts .", "label": "", "metadata": {}, "score": "52.790924"}
{"text": "Immediate versus deferred treatment in infants .Violari et al .Early antiretroviral therapy and mortality among HIV - infected infants .N Engl J Med .", "label": "", "metadata": {}, "score": "52.79371"}
{"text": "In this report , we examine immunologic response , mortality , and program retention in a large cohort of ART - eligible pregnant and nonpregnant women , and men during the first 30 months of treatment .", "label": "", "metadata": {}, "score": "52.865257"}
{"text": "The World Health Organisation treatment guidelines for resource - limited settings explain when HAART should be commenced and what precise combination of antiretrovirals should be used .", "label": "", "metadata": {}, "score": "53.19607"}
{"text": "TB incidence rates in the overall cohort and within CD4 cell count strata were calculated and Kaplan - Meier ( product limit ) calculations were used to estimate TB - free survival .", "label": "", "metadata": {}, "score": "53.207184"}
{"text": "Nowadays it is prescribed in much lower doses ( usually 500 mg per day ) .Cochrane review of AZT trials for mother - to - child transmission HIV reduction .", "label": "", "metadata": {}, "score": "53.25055"}
{"text": "For some , this may reflect disengagement from HIV care postnatally , which needs addressing , particularly for women initiating ART late in their subsequent pregnancy .", "label": "", "metadata": {}, "score": "53.538975"}
{"text": "These data substantially extend the findings of previous studies [ 7 - 11 ] , providing important insights that will assist in the development of approaches to address the challenge of HIV - associated TB .", "label": "", "metadata": {}, "score": "53.54462"}
{"text": "These data suggest that ' unmasking ' TB may account for over one - third of TB cases presenting during the initial months of ART in this setting .", "label": "", "metadata": {}, "score": "53.62526"}
{"text": "Because second line regimens are expensive and there are limited options for third line treatment in most resource limited settings , use of clinical monitoring could have additional long term drawbacks .", "label": "", "metadata": {}, "score": "53.636932"}
{"text": "During long - term ART , a very strong independent association between TB rates and updated CD4 cell counts was observed .At CD4 cell counts of 200 - 500 cells / \u03bcl , TB incidence rates remained high but were significantly lower at CD4 cell counts exceeding a threshold of 500 cells / \u03bcl .", "label": "", "metadata": {}, "score": "53.850346"}
{"text": "J Acquir Immune Defic Syndr 2007 ; 46 : 187 - 93 .[PubMed ] .Antiretroviral Therapy Cohort Collaboration .Life expectancy of individuals on combination antiretroviral therapy in high - income countries : a collaborative analysis of 14 cohort studies .", "label": "", "metadata": {}, "score": "53.931004"}
{"text": "Combination antiretroviral therapy was associated with the most benefit ...[ our emphasis ] .Swiss Cohort .Sterne et al .( 2005 )Long - term effectiveness of potent antiretroviral therapy in preventing AIDS and death : a prospective cohort study .", "label": "", "metadata": {}, "score": "53.953217"}
{"text": "High persisting tuberculosis rates during long - term antiretroviral therapy .As the extent of CD4 cell count recovery was the dominant association with long - term TB incidence rates , we next examined how CD4 cell counts changed over 4 years of ART ( Fig .", "label": "", "metadata": {}, "score": "53.97836"}
{"text": "( 2006 )Antiretrovirals for reducing the risk of mother - to - child transmission of HIV infection .The Cochrane Database of Systematic Reviews 2006 Issue 2 .", "label": "", "metadata": {}, "score": "54.029922"}
{"text": "Discontinuation of antiretroviral therapy .Of 4583 individuals included in the analysis of ART discontinuation after 1 year , 15.2 , 14.2 and 18.6 % of the 350 or less , 351 - 499 and at least 500 cells / \u03bcl CD4 + cell count groups discontinued ART , respectively .", "label": "", "metadata": {}, "score": "54.055637"}
{"text": "Although participants were randomised at baseline , there were more men in the clinical arm , and at least one study has found that men have worse clinical outcomes during ART than women , although this was mostly because of more advanced immunodeficiency and worse adherence to treatment .", "label": "", "metadata": {}, "score": "54.106026"}
{"text": "[PubMed ] .Moore DM , Hogg RS , Yip B , Wood E , Tyndall M , Braitstein P , et al .Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy .", "label": "", "metadata": {}, "score": "54.216606"}
{"text": "Increasing the CD4 cell count threshold for starting ART will not increase the CD4 cell count of patients at ART initiation unless this is accompanied by interventions to achieve earlier diagnosis of HIV and to improve the linkage between HIV - diagnosis and ART centres ( 27 , 28 ) .", "label": "", "metadata": {}, "score": "54.27134"}
{"text": "Individuals ' follow - up was split into 1-month intervals to create time - updated covariates for viral load , ART regimen , HBV / HCV status and time on ART .", "label": "", "metadata": {}, "score": "54.29415"}
{"text": "Cain LE , Logan R , Robins JM , Sterne JA , Sabin C , Bansi L , et al .When to initiate combined antiretroviral therapy to reduce mortality and AIDS - defining illness in HIV - infected persons in developed countries : an observational study .", "label": "", "metadata": {}, "score": "54.300293"}
{"text": "In light of our findings , a logical approach might be to consider initiating IPT after completion of the first few months of ART .Strengths of this study include good patient retention and ascertainment of outcomes , frequent monitoring of CD4 cell counts and the novel analytic approach .", "label": "", "metadata": {}, "score": "54.3285"}
{"text": "Then when they do eventually get AIDS , the drug no longer has a useful effect .With today 's standard of triple - drug therapy , resistance takes , on average , a few years to develop , but resistance is probably not inevitable .", "label": "", "metadata": {}, "score": "54.439865"}
{"text": "Higher rates of discontinuation were observed in those starting ART with a CD4 + cell count between 351 and 499 cells / \u03bcl in a small group of centres , but presence of a LDAE was not associated with ART discontinuation .", "label": "", "metadata": {}, "score": "54.61351"}
{"text": "The high long - term TB incidence is strongly associated with the proportion of person - time at CD4 cell counts less than 500 cells / \u03bcl and adjunctive TB prevention interventions are undoubtedly needed .", "label": "", "metadata": {}, "score": "54.625885"}
{"text": "In recent years , access to antiretroviral therapy ( ART ) has been rapidly scaled up in the countries of sub - Saharan Africa , which have borne the brunt of the dual tuberculosis ( TB ) and HIV epidemics .", "label": "", "metadata": {}, "score": "54.66623"}
{"text": "Conclusion : Updated CD4 cell counts were the dominant predictor of TB risk during ART in this low - resource setting .Among those with baseline CD4 cell counts less than 200 cells / \u03bcl , the excess adjusted risk of TB during early ART was consistent with ' unmasking ' of disease missed at baseline screening .", "label": "", "metadata": {}, "score": "54.740685"}
{"text": "First antenatal CD4 + cell counts , prior to ART initiation , were used .UK national guidelines have recommended a treatment threshold of less than 350 cells / \u03bcl since 2008 [ 13,14 ] .", "label": "", "metadata": {}, "score": "54.766754"}
{"text": "In addition , all participants switched to second line treatment in the CD4 cell count monitoring arm had detectable viral load , and those in the CD4 arm with virological failure who were not switched mostly had low or undetectable viral load six months later .", "label": "", "metadata": {}, "score": "54.780178"}
{"text": "The occurrence of grade 3/4 LDAEs was not independently associated with increased discontinuation rates , an observation in agreement with the recent publication of the UK Register of HIV Seroconverters [ 21 ] .", "label": "", "metadata": {}, "score": "54.893616"}
{"text": "Fig . 1 .Stacked graph of the status of HIV patients since antiretroviral therapy ( ART ) initiation .Table 2 .Cumulative incidence and 95 % confidence interval of attrition ( mortality or loss to follow up ) , mortality , and loss to follow up at 0.5 , 1 , 2 , 3 , 4 , and 5 years after antiretroviral therapy initiation .", "label": "", "metadata": {}, "score": "54.96264"}
{"text": "Although this analysis only examined incident TB from the time of ART initiation , other factors occurring just prior to this may have influenced the findings .", "label": "", "metadata": {}, "score": "55.362755"}
{"text": "Individuals starting ART with a CD4 + cell count at least 500 cells / \u03bcl had a 44 % increased risk of grade 3/4 LDAE compared with those initiating ART with a CD4 + cell count 350 cells / \u03bcl or less .", "label": "", "metadata": {}, "score": "55.450424"}
{"text": "Results of these were made available to study physicians as appropriate to the participants ' assignment arm .All participants underwent a CD4 cell count at study enrolment to determine eligibility for ART .", "label": "", "metadata": {}, "score": "55.51092"}
{"text": "( 2002 ) Systematic review and meta - analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy .BMJ 2002;324:757 .This meta - analysis of 54 antiretroviral clinical trials has demonstrated that : .", "label": "", "metadata": {}, "score": "55.567192"}
{"text": "Study examines best time for healthy HIV - infected people to begin antiretrovirals .March 7 , 2011 .A major new clinical trial seeks to determine whether HIV - infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later , based on their level of CD4 + T - cells .", "label": "", "metadata": {}, "score": "55.660355"}
{"text": "We noted lower mortality rates in our population of adults initiating ART as compared with other studies in the literature .Most programs have reported higher mortality rates , 5.5 - 9.7 per 100 person - years of follow - up , during the first few months of treatment attributed to the highly advanced disease status of many of the patients [ 16,55,56 ] .", "label": "", "metadata": {}, "score": "55.71418"}
{"text": "Immune recovery in this cohort compared very favourably with that observed in ART cohorts in high - income countries [ 40 ] .However , despite excellent immune recovery , the large majority of person - time in this cohort accrued at CD4 cell counts less than 500 cells / \u03bcl , with TB rates ranging between 4.2 and 16.8 cases/100 person - years .", "label": "", "metadata": {}, "score": "55.859062"}
{"text": "[PubMed ] .Bagchi S , Kempf MC , Westfall AO , Maherya A , Willig J , Saag MS .Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource - limited settings ?", "label": "", "metadata": {}, "score": "55.886284"}
{"text": "Individuals were included in this study if they initiated ART between 2000 and 2010 at a UK CHIC centre that provided laboratory data .Those excluded were pregnant women , those with a viral load less than 50 copies HIV RNA / ml at ART initiation and those without at least one CD4 + cell count , viral load or laboratory measurement during follow - up .", "label": "", "metadata": {}, "score": "55.900574"}
{"text": "Use of IPT concurrently with ART is likely to reduce long - term TB rates [ 42 ] but data from randomized controlled trials are awaited [ 43 ] .", "label": "", "metadata": {}, "score": "56.062435"}
{"text": "Also , if the patients who took AZT immediately progressed to AIDS faster than the placebo group then one could conclude that AZT in patients without AIDS symptoms is dangerous .", "label": "", "metadata": {}, "score": "56.10318"}
{"text": "In patients who develop ' unmasking ' TB , rapid immune recovery is thought to trigger host inflammatory responses and development of symptomatic disease [ 20 ] .", "label": "", "metadata": {}, "score": "56.13272"}
{"text": "A steep risk gradient was observed between the highest and lowest CD4 cell strata with a more than 9-fold difference in adjusted rates .", "label": "", "metadata": {}, "score": "56.16284"}
{"text": "Discussion .This study is one of the first to report on immunologic outcomes , mortality , and program retention for ART - eligible women starting ART during pregnancy .", "label": "", "metadata": {}, "score": "56.18008"}
{"text": "J Am Med Assoc 2012 ;308:387 - 402 .Ahmed S , Kim MH , Abrams EJ .Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women : a review of the evidence for the Option B+ approach .", "label": "", "metadata": {}, "score": "56.26448"}
{"text": "In pregnant women who initiated ART , the mean observed CD4 + cell count increased from 147 cells / \u03bcl at baseline to 370 cells / \u03bcl at 12 months and 451 cells / \u03bcl at 30 months of follow - up .", "label": "", "metadata": {}, "score": "56.31058"}
{"text": "We also performed per protocol analyses that included only participants who received ART for at least 90 days as the different monitoring regimens would not theoretically affect outcomes until the time of the first blood sample .", "label": "", "metadata": {}, "score": "56.32614"}
{"text": "Read more \" . ... contribution that severe malnutrition makes to CD4 lymphopenia in HIV - infected and -uninfected children and to determine the changes in CD4 count during nutritional rehabilitation .", "label": "", "metadata": {}, "score": "56.439423"}
{"text": "Martin F , Navaratne L , Khan W , Sarner L , Mercey D , Anderson J , et al .Pregnant women with HIV infection can expect healthy survival : three - year follow - up .", "label": "", "metadata": {}, "score": "56.479965"}
{"text": "This study has several strengths .Sites followed standardized MTCT - Plus protocols , received standardized MTCT - Plus training prior to start - up , and used standardized data collection forms .", "label": "", "metadata": {}, "score": "56.557255"}
{"text": "Thus , in this analysis , only 12 % of person - time was associated with the lowest TB rates achievable during ART ( 1.5 cases/100 person - years ) .", "label": "", "metadata": {}, "score": "56.839134"}
{"text": "Read more \" . ... world , treatment has generally begun only when the count falls to 200 .UNAIDS recently adopted a strategy of initiating ARVs when CD4 counts reach 350 or lower .", "label": "", "metadata": {}, "score": "56.88635"}
{"text": "Read more \" . ... world , treatment has generally begun only when the count falls to 200 .UNAIDS recently adopted a strategy of initiating ARVs when CD4 counts reach 350 or lower .", "label": "", "metadata": {}, "score": "56.88635"}
{"text": "Several studies have concluded that clinical indicators and changes in CD4 cell count are not good predictors of virological failure .17 24 25 26 In our study , however , people in the CD4 cell count monitoring arm did better than those with clinical monitoring alone .", "label": "", "metadata": {}, "score": "56.956654"}
{"text": "Women with severe immunodeficiency or WHO stage 4 disease are less likely to become pregnant [ 45 ] .Baseline CD4 + cell counts for nonpregnant women were somewhat higher than pregnant women in our cohort , but we hypothesize that this may be due to hemodilution , which occurs during pregnancy [ 46 - 48 ] .", "label": "", "metadata": {}, "score": "56.964447"}
{"text": "Thus , individuals who were at highest risk for poor outcomes were excluded from the analysis , either due to early death or their inability to return for follow - up visits .", "label": "", "metadata": {}, "score": "56.978775"}
{"text": "Nash D , Katyal M , Brinkhof MW , Tuboi S , Braitstein P , Balestre E , et al .Long - term CD4 response to potent ART among ART - naive patients in several low - income countries .", "label": "", "metadata": {}, "score": "57.250843"}
{"text": "If this is the case , then why do people do better when they take more antiretrovirals ?The denialists can not rationally explain this .", "label": "", "metadata": {}, "score": "57.30517"}
{"text": "Other obstacles continue to limit the number of people taking ART and the ability of health systems to effectively monitor patients , including inadequate number of physicians and allied health staff 2 and limited laboratory capacity .", "label": "", "metadata": {}, "score": "57.574764"}
{"text": "Although all the sites used the same treatment protocols , some sites faced programmatic challenges such as staff retention , staff education / training , and effective execution of patient adherence protocols .", "label": "", "metadata": {}, "score": "57.627483"}
{"text": "Study design .Participants who had taken ART previously were enrolled in the study , but unless use consisted only of nevirapine for prevention of mother to child transmission they were excluded from analyses .", "label": "", "metadata": {}, "score": "57.64686"}
{"text": "A very strong independent association between TB risk and updated CD4 cell counts during ART was observed ( Table 2 ) .The adjusted TB rate associated with the lowest CD4 cell stratum was more than nine - fold higher than the rate associated with the highest CD4 cell stratum .", "label": "", "metadata": {}, "score": "57.765434"}
{"text": "Similar results were seen when we compared the clinical arm with the CD4 arm ( table 3 ) and using a per protocol analysis ( data not shown ) .", "label": "", "metadata": {}, "score": "57.79218"}
{"text": "A TB screening questionnaire was used routinely at baseline to identify symptomatic patients for TB investigations , and during ART investigations for TB were conducted when clinically indicated .", "label": "", "metadata": {}, "score": "58.037766"}
{"text": "[PubMed ] .Bisson GP , Gross R , Strom JB , Rollins C , Bellamy S , Weinstein R , et al .Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "58.06562"}
{"text": "In this cohort , in addition to baseline CD4 + cell count , sex and pregnancy status , age , and country of enrollment were also associated with immunologic response .", "label": "", "metadata": {}, "score": "58.131027"}
{"text": "John L , Baalwa J , Kalimugogo P , Nabankema E , Castelnuovo B , Muhindo G , et al .Response to ' Does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy ? '", "label": "", "metadata": {}, "score": "58.131626"}
{"text": "Trop Med Int Health 2007 ; 12:1472 - 1474 .Westreich D , Eron J , Behets F , Horst C , Van Rie A. Survival in women exposed to single - dose nevirapine for prevention of mother - to - child transmission of HIV : a stochastic model .", "label": "", "metadata": {}, "score": "58.312668"}
{"text": "Brinkhof MW , Dabis F , Myer L , Bangsberg DR , Boulle A , Nash D , et al .Early loss of HIV - infected patients on potent antiretroviral therapy programmes in lower - income countries .", "label": "", "metadata": {}, "score": "58.373158"}
{"text": "Although the median time of ART initiation in the postpartum cohort was 11 months , previous NVP exposure may have impacted early and long - term CD4 + outcomes , blunting the response in those women with more proximal exposure .", "label": "", "metadata": {}, "score": "58.677826"}
{"text": "NIH ( 2006 ) International HIV / AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy .This randomised trial compared patients who took HAART continuously to patients who took structured treatment breaks .", "label": "", "metadata": {}, "score": "58.68035"}
{"text": "Excluding those with HBV / HCV coinfection or those who started a nevirapine regimen with a CD4 + cell count greater than 350 cells / \u03bcl did not alter our conclusions ( results not shown ) .", "label": "", "metadata": {}, "score": "58.744286"}
{"text": "Statistical analysis .Observation was censored in January 2007 .Adults who were receiving triple - drug ART at enrollment or had previous exposure to ART or initiated ART at a CD4 + cell count of more than 350 cells / \u03bcl were excluded from this analysis .", "label": "", "metadata": {}, "score": "58.90245"}
{"text": "Lodi S , Phillips A , Fidler S , Hawkins D , Gilson R , McLean K , et al . on behalf of the UK Register of HIV Seroconverters Role of HIV infection duration and CD4 cell level at initiation of combination antiretroviral therapy on risk of virological failure .", "label": "", "metadata": {}, "score": "59.01841"}
{"text": "AIDS denialists say that the risks of antiretrovirals outweigh their benefits .If this is the case , then surely mortality should be higher , rather than lower , in patients who start taking them earlier ?", "label": "", "metadata": {}, "score": "59.04103"}
{"text": "The AIDS Clinical Trials Group .Ann Intern Med .1990 May 15;112(10):727 - 37 .In this study , no difference in disease progression was noted among participants who began the trial with CD4 + T cell counts greater than 500/mm3 . \"", "label": "", "metadata": {}, "score": "59.07156"}
{"text": "Nevirapine .Clinical trials demonstrating the efficacy of nevirapine in reducing HIV viral load and increasing CD4 counts are described in the drug 's FDA package insert .", "label": "", "metadata": {}, "score": "59.25717"}
{"text": "Our results should be interpreted in the light of some international guidelines now recommending ART initiation regardless of CD4 + cell count [ 15,16 ] , and the debate around potential benefits and risks of option B+ [ 17 ] .", "label": "", "metadata": {}, "score": "59.300995"}
{"text": "Time - updated Cox proportional hazards models investigated associations between CD4 + cell count and LDAE and the risk of discontinuing ART considering the same covariates as listed above as well as LDAE as a time - updated covariate .", "label": "", "metadata": {}, "score": "59.395645"}
{"text": "Marazzi MC , Liotta G , Germano P , Guidotti G , Altan AD , Ceffa S , et al .Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource - limited settings .", "label": "", "metadata": {}, "score": "59.40616"}
{"text": "[PubMed ] .Nicastri E , Chiesi A , Angeletti C , Sarmati L , Palmisano L , Geraci A , et al .Clinical outcome after 4 years follow - up of HIV - seropositive subjects with incomplete virologic or immunologic response to HAART .", "label": "", "metadata": {}, "score": "59.628452"}
{"text": "Sterne JA , May M , Costagliola D , de Wolf F , Phillips AN , Harris R , et al .Timing of initiation of antiretroviral therapy in AIDS - free HIV-1-infected patients : a collaborative analysis of 18 HIV cohort studies .", "label": "", "metadata": {}, "score": "59.79293"}
{"text": "In the CD4 arm , we changed people if they had a poor immunological response .All of those individuals switched , however , had detectable viral load , indicating a reasonable concordance between CD4 and viral load monitoring .", "label": "", "metadata": {}, "score": "60.155884"}
{"text": "Palacios R , Senise J , Vaz M , Diaz R , Castelo A. Short - term antiretroviral therapy to prevent mother - to - child transmission is safe and results in a sustained increase in CD4 T - cell counts in HIV-1-infected mothers .", "label": "", "metadata": {}, "score": "60.216694"}
{"text": "( 2004 ) Initiating highly active antiretroviral therapy in sub - Saharan Africa : an assessment of the revised World Health Organization scaling - up guidelines .", "label": "", "metadata": {}, "score": "60.47263"}
{"text": "ARTN e63916 CrossRef .Clinical Infectious Diseases Prevention of Tuberculosis in People Living with HIV Granich , R ; Akolo , C ; Gunneberg , C ; Getahun , H ; Williams , P ; Williams , B Clinical Infectious Diseases , 50 ( ) : S215-S222 .", "label": "", "metadata": {}, "score": "60.57742"}
{"text": "This can be confusing for clinicians and policy - makers when determining the best time to initiate therapy .Optimizing the initiation of ART is clearly complex and must , therefore , be balanced between individual and broader public health needs .", "label": "", "metadata": {}, "score": "60.582222"}
{"text": "Similarly , pregnancy was identified as a risk factor for LTF by Wang et al .[ 32 ] in a cohort of adult men and women initiating treatment at four South African community care sites .", "label": "", "metadata": {}, "score": "60.62386"}
{"text": "Whereas mortality risk was found to be largely minimized by the attainment of an updated CD4 cell count of more than 200 cells / \u03bcl , the present study shows that a threshold of more than 500 cells / \u03bcl has to be exceeded to minimize TB rates .", "label": "", "metadata": {}, "score": "60.68009"}
{"text": "Department of Infectious Diseases , Rural Development Trust Hospital , Bathalapalli , India .Abstract .Background : Studies from sub - Saharan Africa have shown high incidence of attrition due to mortality or loss to follow - up ( LTFU ) after initiating antiretroviral therapy ( ART ) .", "label": "", "metadata": {}, "score": "60.862034"}
{"text": "Nash D , Katyal M , Brinkhof MW , Keiser O , May M , Hughes R , et al .Long - term immunologic response to antiretroviral therapy in low - income countries : a collaborative analysis of prospective studies .", "label": "", "metadata": {}, "score": "60.895844"}
{"text": "12 Resistance to lamivudine and nevirapine is already present in 90 % of patients by the time of virological failure , 39 40 but the rate of development of thymidine analogue mutations is variable .", "label": "", "metadata": {}, "score": "60.939587"}
{"text": "Design : Analysis of on - going cohort study .Methods : ART - naive persons initiating ART from 2000 to 2010 were included .Chi - square , analysis of variance ( ANOVA ) and Kruskal - Wallis tests compared characteristics among those starting ART with a CD4 + cell count of 350 or less , 351 - 499 and at least 500 cells / \u03bcl .", "label": "", "metadata": {}, "score": "60.998283"}
{"text": "Breen RA , Smith CJ , Cropley I , Johnson MA , Lipman MC .Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy ?", "label": "", "metadata": {}, "score": "61.05731"}
{"text": "2005 Jul 30-Aug 5;366(9483):346 - 7 .Using leading - edge statistical techniques , the authors calculated that the risk of progression to AIDS or death for patients on HAART in the Swiss Cohort was 14 % of patients not on HAART .", "label": "", "metadata": {}, "score": "61.17529"}
{"text": "Discussion .In this analysis , we calculated TB incidence rates stratified by serially updated CD4 cell counts during ART and compared TB rates during early and long - term treatment .", "label": "", "metadata": {}, "score": "61.19069"}
{"text": "The proportion of patients with a CD4 cell count less than 200 cells / \u03bcl decreased steeply from 89 % at baseline , reaching less than 10 % of patients beyond 128 weeks .", "label": "", "metadata": {}, "score": "61.23171"}
{"text": "Patients who initiated anti - tuberculous treatment after ART initiation had an increased risk of attrition .However , initiating anti - tuberculous treatment before ART was not associated with an increased risk of attrition and was associated with a reduced risk of LTFU in the multivariable analysis .", "label": "", "metadata": {}, "score": "61.310516"}
{"text": "The new Phase IV study , known as the Strategic Timing of Antiretroviral Treatment ( START ) clinical trial , is a randomized clinical trial designed to provide definitive evidence of the risks and benefits of early antiretroviral treatment to more clearly define the optimal time to begin medication .", "label": "", "metadata": {}, "score": "61.481148"}
{"text": "It is hoped that the START and TEMPRANO trials ( RCTs to investigate the risks and benefits to an individual of early ART initiation ) will definitively address this particular question , but these will not report until 2015 [ 12,13 ] .", "label": "", "metadata": {}, "score": "61.48234"}
{"text": "Physicians responsible for patients in the two study arms that included routine viral loads or CD4 counts , or both , received these results on a quarterly basis .", "label": "", "metadata": {}, "score": "61.49729"}
{"text": "During ART , 203 patients developed TB and they had broadly similar baseline characteristics as patients who did not develop TB except that those developing incident TB were less likely to have prevalent TB at baseline ( Table 1 ) .", "label": "", "metadata": {}, "score": "61.60218"}
{"text": "The participants taking AZT immediately had slower disease progression in the first year , but this dissipated with time resulting in no statistical difference in progression to AIDS .", "label": "", "metadata": {}, "score": "61.642"}
{"text": "Orrell C , Harling G , Lawn SD , Kaplan R , McNally M , Bekker LG , et al .Conservation of first - line antiretroviral treatment regimen where therapeutic options are limited .", "label": "", "metadata": {}, "score": "61.77096"}
{"text": "Patel D , Cortina - Borja M , Thorne C , Newell ML .Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV - infected pregnant women .", "label": "", "metadata": {}, "score": "61.907974"}
{"text": "Cohort characteristics and follow - up .During the study period , 2000 consecutive patients were enrolled in the programme .ART was received by 1480 ( 84.4 % ) patients ; these typically had advanced immunodeficiency and many had previous TB diagnoses ( Table 1 ) .", "label": "", "metadata": {}, "score": "61.993217"}
{"text": "Discussion .In this study , it was demonstrated that nearly 40 % of patients who initiate ART die or are LTFU after 5 years of follow - up .", "label": "", "metadata": {}, "score": "62.23244"}
{"text": "It concluded that one should not .If the patients in the placebo arm stayed on placebo and never took AZT when they got AIDS , then a comparison would have been possible ( and we can conclude from the trials described above that such hypothetical patients would have done very badly ) .", "label": "", "metadata": {}, "score": "62.341164"}
{"text": "One thousand , two hundred and eighty - three ( 13.6 % ) patients experienced at least one LDAE .Conclusion : This study demonstrates the need to consider ART - related toxicities when initiating therapy at CD4 + cell counts at least 500 cells / \u03bcl .", "label": "", "metadata": {}, "score": "62.500744"}
{"text": "Koenig SP , Riviere C , Leger P , Joseph P , Severe P , Parker K , et al .High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy .", "label": "", "metadata": {}, "score": "62.668987"}
{"text": "However , the study had several limitations .The data were derived from a clinical care program rather than a research study .Thus , there may have been variability across the program CD4 + cell counts , as measurements were done in local laboratories .", "label": "", "metadata": {}, "score": "62.725533"}
{"text": "Microbiological specimens were processed within nationally accredited laboratories .Blood CD4 cell counts ( CD4 cell counts ) and plasma viral load measurements were done routinely at baseline and 4-monthly during ART together with clinical review .", "label": "", "metadata": {}, "score": "62.849846"}
{"text": "Although START will primarily look at major health outcomes associated with immediate and deferred antiretroviral therapy , the study will also examine HIV transmission risk behaviors , treatment adherence , drug resistance , health care utilization and the cost of care .", "label": "", "metadata": {}, "score": "62.854237"}
{"text": "Typically , HIV infected individuals who are found to be eligible for ART receive two or three sessions of ART preparedness counselling before initiating ART ( 25 ) .", "label": "", "metadata": {}, "score": "62.91821"}
{"text": "Read PJ , Mandalia S , Khan P , Harrisson U , Naftalin C , Gilleece Y , et al .When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery ?", "label": "", "metadata": {}, "score": "63.100014"}
{"text": "An additional 541 ( 24 % ) male partners also began ART .The median age for all patients initiating treatment was 30 years ( IQR 27 - 34 ) and the median baseline CD4 + cell count was 155 cells / \u03bcl ( IQR 95 - 195 ) ( Table 1 ) .", "label": "", "metadata": {}, "score": "63.188663"}
{"text": "After 30 months on ART retention was 0.85 with no retention differences between pregnant women , nonpregnant women , and men .Conclusion : HIV - infected women in resource - limited countries who start ART during pregnancy have similar or better long - term CD4 + cell count responses as compared with other adults .", "label": "", "metadata": {}, "score": "63.229748"}
{"text": "After five years of follow - up , survival was 87 % ( 95 % confidence interval 85 % to 88 % ) in the clinical monitoring arm and 90 % ( 88 % to 91 % ) in the clinical plus CD4 cell count monitoring arm .", "label": "", "metadata": {}, "score": "63.335896"}
{"text": "16 % of the infants in the delayed group died versus 4 % of the immediately treated infants , a 75 % improvement .Again , this result can not be explained by the AIDS denialist position that the toxicity of HAART outweighs its benefits .", "label": "", "metadata": {}, "score": "63.44296"}
{"text": "Traditionally , therapy is administered based on a patient 's CD4 cell count , where the number of CD4 cells reflects the body 's immune ( defense ) system .", "label": "", "metadata": {}, "score": "63.672264"}
{"text": "Results .A total of 14 022 individuals commenced ART after 2000 in a centre that provided laboratory data .Of these , 3068 were excluded with viral load less than 50 copies / ml at ART start , 534 had no follow - up , 363 had no CD4 + cell count , 432 were pregnant and 219 had no laboratory measures .", "label": "", "metadata": {}, "score": "63.78365"}
{"text": "AIDS 2000 ; 14:1985 - 1991 .Jones JL , Hanson DL , Dworkin MS , DeCock KM .HIV - associated tuberculosis in the era of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "63.784508"}
{"text": "[PubMed ] .Bedelu M , Ford N , Hilderbrand K , Reuter H. Implementing antiretroviral therapy in rural communities : the Lusikisiki model of decentralized HIV / AIDS care .", "label": "", "metadata": {}, "score": "63.848957"}
{"text": "Ouattara E , Danel C , Moh R , Gabillard D , Peytavin G , Konan R , et al .Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts .", "label": "", "metadata": {}, "score": "64.01605"}
{"text": "Chi BH , Sinkala M , Stringer EM , Cantrell RA , Mtonga V , Bulterys M , et al .Early clinical and immune response to NNRTI - based antiretroviral therapy among women with prior exposure to single - dose nevirapine .", "label": "", "metadata": {}, "score": "64.03854"}
{"text": "In addition , the MTCT - Plus model of care emphasized psychosocial support and adherence to care and treatment as critical components of the program .", "label": "", "metadata": {}, "score": "64.09994"}
{"text": "Methods : Mean population changes were assessed and multivariable mixed linear regression modeling was used to examine covariate effects on differences in absolute CD4 + cell count responses .", "label": "", "metadata": {}, "score": "64.18229"}
{"text": "N Engl J Med .1987 Jul 23;317(4):185 - 91 .This trial is described as follows by NIAID : \" A clinical trial known as BW 002 compared AZT with placebo in 282 patients with AIDS or advanced signs or symptoms of HIV disease .", "label": "", "metadata": {}, "score": "64.21943"}
{"text": "Figures are numbers ( percentages where shown ) .Among the 17 people in the clinical arm with virological failure who were not switched to second line treament , however , only two deaths and no opportunistic infections occurred .", "label": "", "metadata": {}, "score": "64.45132"}
{"text": "[PubMed ] .Barth RE , van der Loeff MF , Schuurman R , Hoepelman AI , Wensing AM .Virological follow - up of adult patients in antiretroviral treatment programmes in sub - Saharan Africa : a systematic review .", "label": "", "metadata": {}, "score": "64.54304"}
{"text": "Coovadia A , Hunt G , Abrams EJ , Sherman G , Meyers T , Barry G , et al .Persistent minority K103N mutations among women exposed to single - dose nevirapine and virologic response to nonnucleoside reverse - transcriptase inhibitor - based therapy .", "label": "", "metadata": {}, "score": "64.59451"}
{"text": "Ekouevi D , Abrams EJ , Schlesinger M , Myer L , Phanuphak N , Carter RJ .Maternal CD4 + cell count decline after interruption of antiretroviral prophylaxis for the prevention of mother - to - child transmission of HIV .", "label": "", "metadata": {}, "score": "64.61435"}
{"text": "A total of 1794 patients had both a baseline and at least one CD4 + cell count measurement after initiating ART .A total of 7889 CD4 + cell count measurements were recorded up to the 30-month visit following ART initiation with a median of four measurements ( range 2 - 9 ) per patient .", "label": "", "metadata": {}, "score": "64.61753"}
{"text": "J Acquir Immune De&filig;c Syndr 2012 ; 59:287 - 293 .Gazzard BG , Anderson J , Babiker A , Boffito M , Brook G , Brough G , et al .", "label": "", "metadata": {}, "score": "64.78172"}
{"text": "2 C ) .Figure 3 presents the cumulative incidence of attrition , mortality , and LTFU by the timing of tuberculosis diagnosis .Patients diagnosed with tuberculosis after ART initiation had higher incidence of attrition ( 47.4 % ) and mortality ( 31.6 % ) after 4 years of follow - up .", "label": "", "metadata": {}, "score": "64.82297"}
{"text": "[PubMed ] .Harries AD , Schouten EJ , Libamba E. Scaling up antiretroviral treatment in resource - poor settings .Lancet 2006 ; 367 : 1870 - 2 .", "label": "", "metadata": {}, "score": "64.83246"}
{"text": "Mortality .There was no significant difference in mortality between the CD4 and viral load arms ( 1.10 .0.69 to 1.75 ) .In the per protocol analysis , there were similar but non - significant trends ( table 2 \u200b 2 ) .", "label": "", "metadata": {}, "score": "64.918205"}
{"text": "At program entry , patients had a physical examination , WHO staging , and CD4 + cell count done locally .The CD4 + cell count was repeated every 6 months .", "label": "", "metadata": {}, "score": "65.04647"}
{"text": "Nonpregnant women had a similar , although less steep , increase in CD4 + cell count response over time .In addition to sex and pregnancy status , age , baseline CD4 + cell count , and country of enrollment were each associated with a significant increase in CD4 + cell count ( Table 2 ) .", "label": "", "metadata": {}, "score": "65.2165"}
{"text": "Cumulative incidences of mortality and LTFU were calculated using competing risk analysis ( stcompet command in Stata ) ( 21 ) .Results .We identified 3,159 patients who initiated ART .", "label": "", "metadata": {}, "score": "65.29476"}
{"text": "It is not clear whether longer term follow - up would show benefits to viral load testing .An evaluation with data from resource limited countries found no evidence of improved mortality in programmes with viral load testing , 38 but follow - up was relatively short .", "label": "", "metadata": {}, "score": "65.39307"}
{"text": "Of 9406 patients , 7860 ( 83.6 % ) , 1099 ( 11.7 % ) and 447 ( 4.8 % ) started ART with a CD4 + cell count of 350 or less , 351 - 499 and at least 500 cells / \u03bcl , respectively .", "label": "", "metadata": {}, "score": "65.58043"}
{"text": "If you have or suspect you may have a health problem , consult your health care provider .Abstract .Objective To evaluate the use of routine laboratory monitoring in terms of clinical outcomes among patients receiving antiretroviral therapy ( ART ) in Uganda .", "label": "", "metadata": {}, "score": "65.63884"}
{"text": "Using two antiretrovirals reduced progression to AIDS or death by 40 % against one antiretroviral .Using three antiretrovirals reduced progression to AIDS or death by 40 % against two antiretrovirals .", "label": "", "metadata": {}, "score": "65.648926"}
{"text": "Babiker AG , Emery S , Fatkenheuer G , Gordin FM , Grund B , Lundgren JD , et al .Considerations in the rationale , design and methods of the Strategic Timing of AntiRetroviral Treatment ( START ) study .", "label": "", "metadata": {}, "score": "65.67613"}
{"text": "J Acquir Immune Defic Syndr 2003 ; 34 ( Suppl 1):S21-S33 .Lodi S , Phillips A , Touloumi G , Geskus R , Meyer L , Thiebaut R , et al .", "label": "", "metadata": {}, "score": "65.97122"}
{"text": "References .Samb B , Celletti F , Holloway J , Van Damme W , De Cock KM , Dybul M. Rapid expansion of the health workforce in response to the HIV epidemic .", "label": "", "metadata": {}, "score": "66.05991"}
{"text": "Lastly , although diagnostic procedures for opportunistic infections were identical across arms , clinicians could not be blinded , and they might have more intensively examined participants in the clinical arm for illness .", "label": "", "metadata": {}, "score": "66.35982"}
{"text": "These congregate clinical settings are also associated with substantial risk of transmission of both drug - susceptible and multidrug - resistant TB [ 14,15 ] .", "label": "", "metadata": {}, "score": "66.370926"}
{"text": "Abstract .Those initiating ART during pregnancy had a 4.3-fold increased odds of detectable viral load at delivery compared with those conceiving on treatment , suggesting that continuation of ART after pregnancy may be beneficial for many women .", "label": "", "metadata": {}, "score": "66.40109"}
{"text": "Both studies compared the effect of ART initiation at high CD4 counts ( 350 cells / \u03bcL ) with ART initiation at low CD4 counts ( 250 cells / \u03bcL ) .", "label": "", "metadata": {}, "score": "66.453995"}
{"text": "The overall TB incidence rate during follow - up was 7.28 cases/100 person - years ( 95%CI , 6.32 - 8.36 ) .A strong graded association was observed with the highest TB rates during person - time accrued within the less than 100 cells / \u03bcl CD4 cell stratum and the lowest during person - time accumulated within the more than 500 cells / \u03bcl CD4 cell stratum ( Fig . 1 ) .", "label": "", "metadata": {}, "score": "66.47765"}
{"text": "As a sensitivity analysis , the model was re - run using the original non - imputed viral load variable ; the adjusted odds ratio ( aOR ) was similar [ 3.85 , 95 % confidence interval ( CI ) 2.65 - 5.59].", "label": "", "metadata": {}, "score": "66.512344"}
{"text": "At baseline , the median viral load was 216 000 copies / mL ( interquartile range 72 000 - 536 000 ) .Of 1047 participants in the per protocol analysis , 28 ( 2.8 % ) were changed to a regimen containing a protease inhibitor ( table 4 \u200b 4 ) . )", "label": "", "metadata": {}, "score": "66.55867"}
{"text": "The authors have not received any funding or benefits from industry or elsewhere to conduct this study .Eaton JW , Johnson LF , Salomon JA , B\u00e4rnighausen T , Bendavid E , Bershteyn A , et al .", "label": "", "metadata": {}, "score": "66.55966"}
{"text": "N Engl J Med .1996 Oct 10;335(15):1081 - 90 .This trial compared AZT experienced patients randomly assigned to taking didanosine versus AZT experienced patients who continued to take AZT .", "label": "", "metadata": {}, "score": "66.59095"}
{"text": "Hazard ratios and incidence rate ratios were adjusted for age , sex , and baseline CD4 cell count , viral load , and BMI , unless otherwise specified .", "label": "", "metadata": {}, "score": "66.63013"}
{"text": "Wood R , Middelkoop K , Myer L , Grant AD , Whitelaw A , Lawn SD , et al .Undiagnosed tuberculosis in a community with high HIV prevalence : implications for tuberculosis control .", "label": "", "metadata": {}, "score": "66.82074"}
{"text": "Neither CD4 + cell count nor LDAEs were associated with discontinuation of ART after 1 year ( results not shown ) .In 1746 individuals attending centres not involved in the SPARTAC study , 27.8 , 28.6 and 31.3 % of those who started ART with a CD4 + cell count 350 or less , 351 - 499 and at least 500 cells / \u03bcl discontinued ART .", "label": "", "metadata": {}, "score": "66.9428"}
{"text": "Data analysis .Data were analysed using STATA version 10.0 ( College Station , Texas , USA ) .Data from all patients who initiated ART between September 2002 and March 2006 were included .", "label": "", "metadata": {}, "score": "66.96759"}
{"text": "In 2003 - 2004 , adults were considered eligible for ART if they met the following criteria : WHO stage 4 or CD4 + cell count 200 cells / \u03bcl or less or WHO stage 2 or 3 and CD4 + cell count 350 cells / \u03bcl or less .", "label": "", "metadata": {}, "score": "67.01935"}
{"text": "National ART guidelines were based on WHO 2002 recommendations [ 23 ] , providing free treatment for those with a prior AIDS diagnosis ( WHO stage 4 disease ) or a blood CD4 cell count less than 200 cells / \u03bcl .", "label": "", "metadata": {}, "score": "67.09571"}
{"text": "After inclusion in the study , 360 participants in the viral load arm , 364 in the CD4 arm , and 370 in the clinical arm started ART .", "label": "", "metadata": {}, "score": "67.18001"}
{"text": "We combined the mortality data for both trials comparing initiating ART at CD4 levels at 350 cells/\u00b5L or between 200 and 350 cells/\u00b5L with deferring initiation of ART to CD4 levels of 250 cells/\u00b5L or 200 cells/\u00b5L. There was a statistically significant reduction in death when starting ART at higher CD4 counts .", "label": "", "metadata": {}, "score": "67.210976"}
{"text": "Lawn SD , Edwards DJ , Kranzer K , Vogt M , Bekker LG , Wood R. , Urine lipoarabinomannan assay for tuberculosis screening prior to ART : diagnostic yield and association with immune reconstitution disease .", "label": "", "metadata": {}, "score": "67.338165"}
{"text": "Lancet 2006 ; 367 : 817 - 24 .[PubMed ] .Sungkanuparph S , Manosuthi W , Kiertiburanakul S , Piyavong B , Chumpathat N , Chantratita W. Options for a second - line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed - dose combination of stavudine , lamivudine , and nevirapine fails .", "label": "", "metadata": {}, "score": "67.342926"}
{"text": "The median CD4 cell count was 140 cells/\u00b5l ( IQR 84 - 195 ) .Thirteen percent were diagnosed with tuberculosis within 3 months before ART initiation , and 7.5 % within 3 months after ART initiation .", "label": "", "metadata": {}, "score": "67.37346"}
{"text": "Updated CD4 cell counts were measured 4-monthly .Person - time accrued within a range of CD4 cell count strata ( CD4 cell strata ) was calculated and used to derive CD4 cell - stratified TB rates .", "label": "", "metadata": {}, "score": "67.58175"}
{"text": "Bonnet M , Pinoges L , Varaine F , Oberhauser B , O'Brien D , Kebede Y , et al .Tuberculosis after HAART initiation in HIV - positive patients from five countries with a high tuberculosis burden .", "label": "", "metadata": {}, "score": "67.69179"}
{"text": "Calmy A , Pinoges L , Szumilin E , Zachariah R , Ford N , Ferradini L. Generic fixed - dose combination antiretroviral treatment in resource - poor settings : multicentric observational cohort .", "label": "", "metadata": {}, "score": "67.69553"}
{"text": "The results of this cohort study indicate that the attrition after ART initiation is extremely high .Nearly 40 % of patients die or are LTFU .", "label": "", "metadata": {}, "score": "67.717636"}
{"text": "4 In addition , establishing sophisticated laboratory services at relatively poorly equipped health facilities remains challenging .Consequently , many people taking ART in Africa receive either no routine laboratory follow - up or infrequent measurements of CD4 cell counts .", "label": "", "metadata": {}, "score": "67.93388"}
{"text": "Clinic visit attendance was tracked and outreach protocols were used to contact individuals who failed to attend scheduled visits .Adherence and psychosocial support were emphasized at each appointment and several programs had peer educator or patient support groups to enhance adherence .", "label": "", "metadata": {}, "score": "67.98621"}
{"text": "Overall , 16.2 % ( 273/1686 ) had detectable viral load ( median 188 copies / ml , IQR 90 - 590 , range 51 - 412 000 ) - 26.2 % in women starting ART in pregnancy and 6.3 % among those conceiving on ART ( Table 1 ) .", "label": "", "metadata": {}, "score": "68.04976"}
{"text": "Although the mortality of patients diagnosed with tuberculosis after ART initiation was very high , patients who started anti - tuberculosis treatment before ART had similar attrition to patients without tuberculosis .", "label": "", "metadata": {}, "score": "68.08757"}
{"text": "The study , which ... .Despite growing evidence that the earlier people are diagnosed with HIV and get access to care , the better their clinical outcomes , many HIV - infected people in the United States and Canada are not receiving the care they ... .", "label": "", "metadata": {}, "score": "68.14117"}
{"text": "FDA .( 1996 ) FDA grants accelerated approval to third protease inhibitor to treat HIV .We include the above press release to show that , in contrast to the suggestions of AIDS denialists , indinavir was registered by the FDA on the basis of two trials .", "label": "", "metadata": {}, "score": "68.35538"}
{"text": "Watts DH , Brown ER , Maldonado Y , Herron C , Chipato T , Reddy L , et al .HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial .", "label": "", "metadata": {}, "score": "68.43773"}
{"text": "Conclusions : The vast majority of children achieve viral suppression even in the context of a routine service program .Mortality rates are high during the first few weeks of ART and may reflect failure to identify HIV - infected children early .", "label": "", "metadata": {}, "score": "68.46277"}
{"text": "Garcia F , de Lazzari E , Plana M , Castro P , Mestre G , Nomdedeu M , et al .Long - term CD4 + T - cell response to highly active antiretroviral therapy according to baseline CD4 + T - cell count .", "label": "", "metadata": {}, "score": "68.51463"}
{"text": "HIV attacks CD4 cells , and as time goes by people with HIV often see their CD4 counts drop .The lower your ...Read more \" .", "label": "", "metadata": {}, "score": "68.53402"}
{"text": "This helps address the question of whether lifelong ART might be beneficial for all pregnant women .In the UK / Ireland , pregnancies in diagnosed HIV - positive women are reported to the National Study of HIV in Pregnancy and Childhood ( NSHPC ) as described elsewhere [ 12 ] .", "label": "", "metadata": {}, "score": "68.624214"}
{"text": "( 1990 )The safety and efficacy of zidovudine ( AZT ) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 ( HIV ) infection .", "label": "", "metadata": {}, "score": "68.63567"}
{"text": "Egger M. Antiretroviral therapy in resource - limited settings 1996 to 2006 : patient characteristics , treatment regimens and monitoring in sub - Saharan Africa , Asia and Latin America .", "label": "", "metadata": {}, "score": "68.665695"}
{"text": "START will also feature several sub - studies to be conducted across some of the 200 study sites .Related Stories .The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment , but the optimal timing for starting treatment remains controversial , ... .", "label": "", "metadata": {}, "score": "68.73158"}
{"text": "Unfortunately , the current South African national ART policy restricts eligibility to those with AIDS or a CD4 cell count of less than 200 cells / \u03bcl and therefore greatly undermines the potential benefits of ART for TB prevention .", "label": "", "metadata": {}, "score": "69.06979"}
{"text": "AIDS denialists say that the risks of antiretrovirals outweigh their benefits .If this is the case , then why do people who take antiretrovirals all the time do better than people who take them occasionally ?", "label": "", "metadata": {}, "score": "69.20451"}
{"text": "Longer duration of antenatal ART decreases risk of detectable viral load at delivery , and hence the risk of vertical transmission [ 4,5,25 - 27 ] , but the four - fold increased odds of detectable virus among those initiating ART during , rather than before , pregnancy is striking .", "label": "", "metadata": {}, "score": "69.21187"}
{"text": "Lancet Infect Dis 2008 ; 8:516 - 523 .Goldsack NR , Allen S , Lipman MC .Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "69.302475"}
{"text": "The study is being conducted by the International Network for Strategic Initiatives in Global HIV Trials ( INSIGHT ) , an HIV/ AIDS clinical trial network funded by NIAID .", "label": "", "metadata": {}, "score": "69.350815"}
{"text": "The virological criteria for switching were conservative in relation to switching criteria in industrialised countries , 45 although more liberal than current WHO recommendations , 19 and could have led to underestimation of the effectiveness of viral load monitoring in improving clinical outcomes .", "label": "", "metadata": {}, "score": "69.39555"}
{"text": "The HIV medicines being used in the trial are approved medications donated by Abbott Laboratories , Bristol - Myers Squibb , Gilead Sciences , GlaxoSmithKline , Merck & Co. and Tibotec Pharmaceuticals .", "label": "", "metadata": {}, "score": "69.58687"}
{"text": "Aids 2006 ; 20 : 41 - 8 .[PubMed ] .Rosen S , Fox MP , Gill CJ .Patient retention in antiretroviral therapy programs in sub - Saharan Africa : a systematic review .", "label": "", "metadata": {}, "score": "69.63428"}
{"text": "CD4 + cell count change following antiretroviral therapy initiation .Antiretroviral regimens included NVP for 2012 ( 90 % ) patients , with lamivudine ( 3TC ) and either ZDV or stavudine ( d4 T ) .", "label": "", "metadata": {}, "score": "69.65127"}
{"text": "Analyses of detectable viral load at delivery were conducted on these 1028 women , and 914 women conceiving on ART .Delivery viral loads were reported for similar proportions in both groups : 59.6 % and 54.2 % , respectively .", "label": "", "metadata": {}, "score": "69.68579"}
{"text": "Nicastri E , Leone S , Angeletti C , Palmisano L , Sarmati L , Chiesi A , et al .Sex issues in HIV-1-infected persons during highly active antiretroviral therapy : a systematic review .", "label": "", "metadata": {}, "score": "69.76996"}
{"text": "10.5588/ijtld.13.0032 CrossRef .10.1093/trstmh / trt001 CrossRef .10.1136/thoraxjnl-2012 - 201740 CrossRef .10.1089/aid.2012.0231 CrossRef .Clinical Infectious Diseases Reducing the Burden of Tuberculosis Presenting during the Initial Months of Antiretroviral Therapy in Resource - Limited Settings Lawn , SD ; Edwards , DJ ; Wood , R Clinical Infectious Diseases , 50(1 ) : 124 - 125 . 10.1086/649007 CrossRef .", "label": "", "metadata": {}, "score": "69.81778"}
{"text": "AIDS Patient Care STDS 2004 ; 18 : 189 - 98 .[PubMed ] .Lohse N , Kronborg G , Gerstoft J , Larsen CS , Pedersen G , Pedersen C , et al .", "label": "", "metadata": {}, "score": "69.90317"}
{"text": "Fregonese F , Collins IJ , Jourdain G , Lecoeur S , Cressey TR , Ngo - Giang - Houng N , et al .Predictors of 5-year mortality in HIV - infected adults starting highly active antiretroviral therapy in Thailand .", "label": "", "metadata": {}, "score": "69.90473"}
{"text": "[PubMed ] .Moore DM , Mermin J , Awor A , Yip B , Hogg RS , Montaner JS .Performance of immunologic responses in predicting viral load suppression : implications for monitoring patients in resource - limited settings .", "label": "", "metadata": {}, "score": "70.01118"}
{"text": "Zidovudine ( AZT ) .BW 002 : First phase III AZT clinical trial : .Fischl et a. ( 1987 )The efficacy of azidothymidine ( AZT ) in the treatment of patients with AIDS and AIDS - related complex .", "label": "", "metadata": {}, "score": "70.06619"}
{"text": "The addition of quarterly monitoring of CD4 cell count among adults taking ART in Uganda was associated with better clinical outcomes than clinical monitoring alone .", "label": "", "metadata": {}, "score": "70.07783"}
{"text": "The first line ART regimen was stavudine , lamivudine , and nevirapine ( or efavirenz for those taking concurrent rifampicin ) .Trained lay field officers visited clients ' homes weekly to deliver drugs and collect data regarding drug adherence , potential symptoms of drug toxicity , or death of a household member in the preceding seven days .", "label": "", "metadata": {}, "score": "70.112404"}
{"text": "It found that \" HAART was associated with decreased AIDS [ adjusted rate ratio [ ARR ] , 0.16 ; 95 % confidence interval ( CI ) , 0.08 - 0.31 ) and death ( ARR , 0.10 ; 95 % CI , 0.06 - 0.18 ) .", "label": "", "metadata": {}, "score": "70.112785"}
{"text": "[PubMed ] .Mermin J , Were W , Ekwaru JP , Moore D , Downing R , Behumbiize P , et al .Mortality in HIV - infected Ugandan adults receiving antiretroviral treatment and survival of their HIV - uninfected children : a prospective cohort study .", "label": "", "metadata": {}, "score": "70.160614"}
{"text": "Laboratory procedures .Plasma samples were screened for HIV infection by two enzyme linked immunoassays ( EIA ) in parallel ( Recombigen HIV-1/HIV-2 , Trinity Biotech , Dublin ; and Murex HIV1.2.0 , Abbott diagnostics , Chicago , IL ) .", "label": "", "metadata": {}, "score": "70.206345"}
{"text": "Tonwe - Gold B , Ekouevi DK , Viho I , Amani - Bosse C , Toure S , Coffie PA , et al .Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa : evaluation of a two - tiered approach .", "label": "", "metadata": {}, "score": "70.363266"}
{"text": "Predicted CD4 cell count response did not vary by WHO stage at baseline , but did vary by country .Participants from sites in Cote d'Ivoire had the greatest increase in CD4 cell count at 6 months and at every time point thereafter .", "label": "", "metadata": {}, "score": "70.43257"}
{"text": "Kaplan - Meier estimates of TB - free survival proportions at 1 , 2 and 3 years were 0.89 , 0.85 and 0.82 , respectively .", "label": "", "metadata": {}, "score": "70.678986"}
{"text": "N Engl J Med .2004 Jul 15;351(3):217 - 28 .This study showed that \" A single dose of nevirapine to the mother , with or without a dose of nevirapine to the infant , added to oral zidovudine prophylaxis starting at 28 weeks ' gestation , is highly effective in reducing mother - to - child transmission of HIV . \"", "label": "", "metadata": {}, "score": "70.748405"}
{"text": "Viral load , CD4 was measured pre - treatment and 6-monthly and anthropometric measurements every 3 months .All outcomes through April 2008 were included using survival longitudinal analysis .", "label": "", "metadata": {}, "score": "70.801544"}
{"text": "Median pre - ART antenatal CD4 + cell count at second pregnancy ( available for 838/1177 ) was 390 cells / \u03bcl ( IQR 271 - 534 ) , measured at median 15.0 gestational weeks ( IQR 9.6 - 20.6 ) .", "label": "", "metadata": {}, "score": "70.90699"}
{"text": "AIDS 2002 ; 16:1139 - 1146 .Kebba A , Atwine D , Mwebaze R , Kityo C , Nakityo R , Peter M. Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients .", "label": "", "metadata": {}, "score": "70.92961"}
{"text": "Lawn SD , Myer L , Orrell C , Bekker LG , Wood R. Early mortality among adults accessing a community - based antiretroviral service in South Africa : implications for programme design .", "label": "", "metadata": {}, "score": "71.00246"}
{"text": "Lawn SD , Myer L , Orrell C , Bekker LG , Wood R. Early mortality among adults accessing a community - based antiretroviral service in South Africa : implications for programme design .", "label": "", "metadata": {}, "score": "71.00246"}
{"text": "Strengths and weaknesses .In this randomised trial we examined the efficacy of both routine CD4 cell count and viral load monitoring on clinical outcomes in a resource limited setting .", "label": "", "metadata": {}, "score": "71.31002"}
{"text": "Boehme AK , Davies SL , Moneyham L , Shrestha S , Schumacher J , Kempf MC .A qualitative study on factors impacting HIV care adherence among postpartum HIV - infected women in the rural southeastern USA .", "label": "", "metadata": {}, "score": "71.356064"}
{"text": "Although an earlier calendar year of ART initiation was not associated with attrition after ART initiation , it was associated with an increased risk of LTFU and a reduced risk of death , suggesting that it was more difficult to document the mortality at earlier calendar years .", "label": "", "metadata": {}, "score": "71.62366"}
{"text": "Participants All participants were people with HIV who were members of the AIDS Support Organisation .Interventions Participants were randomised to one of three different monitoring arms : a viral load arm ( clinical monitoring , quarterly CD4 counts , and viral load measurements ) , CD4 arm ( clinical monitoring and CD4 counts ) , or clinical arm ( clinical monitoring alone ) .", "label": "", "metadata": {}, "score": "71.63396"}
{"text": "Wang B , Losina E , Stark R , Munro A , Walensky R , Wilke M , et al .Loss to follow - up in community clinics in South Africa : role of CD4 count , gender and pregnancy [ poster # 841 ] .", "label": "", "metadata": {}, "score": "71.6546"}
{"text": "Baseline characteristics according to CD4 + cell count at ART start were compared using Chi - square and analysis of variance ( ANOVA ) or Kruskal - Wallis tests .", "label": "", "metadata": {}, "score": "72.18873"}
{"text": "HIV Med 2012 ; 13 ( Suppl 2):1 - 85 .Thompson MA , Aberg JA , Hoy JF , Telenti A , Benson C , Cahn P , et al .", "label": "", "metadata": {}, "score": "72.32004"}
{"text": "AIDS 2009 ; 23 : 1127 - 34 .[ PMC free article ] [ PubMed ] .Keiser O , Anastos K , Schechter M , Balestre E , Myer L , Boulle A , et al .", "label": "", "metadata": {}, "score": "72.34274"}
{"text": "Myer L , Rabkin M , Abrams EJ , Rosenfield A , El - Sadr WM .Focus on women : linking HIV care and treatment with reproductive health services in the MTCT - Plus Initiative .", "label": "", "metadata": {}, "score": "72.575005"}
{"text": "The findings and conclusions are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention .Ethical approval : The studies were approved by the Institutional Review Boards of the Centers for Disease Control and Prevention and the Uganda Virus Research Institute and informed consent was given by all patients .", "label": "", "metadata": {}, "score": "72.58618"}
{"text": "Lawn SD , Myer L , Bekker LG , Wood R. CD4 cell count recovery among HIV - infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub - Saharan Africa .", "label": "", "metadata": {}, "score": "72.70221"}
{"text": "Conclusions : In this cohort study , the attrition was similar to the one found in sub - Saharan Africa .Earlier initiation of ART , improving the diagnosis of tuberculosis before initiating ART , and giving more support to those patients at higher risk of attrition could potentially reduce the mortality and LTFU after ART initiation .", "label": "", "metadata": {}, "score": "72.758934"}
{"text": "Day JH , Charalambous S , Fielding KL , Hayes RJ , Churchyard GJ , Grant AD .Screening for tuberculosis prior to isoniazid preventive therapy among HIV - infected gold miners in South Africa .", "label": "", "metadata": {}, "score": "72.78509"}
{"text": "Socio - demographic risk factors associated with HIV infection in patients seeking medical advice in a rural hospital of India .J Public health Res 2012 ; 1 : e14 .", "label": "", "metadata": {}, "score": "72.87811"}
{"text": "The information provided through The Body should not be used for diagnosing or treating a health problem or a disease .It is not a substitute for professional care .", "label": "", "metadata": {}, "score": "72.87819"}
{"text": "Mortality - specific rates were calculated .Kaplan - Meier analysis and the log - rank test were used to assess differences in survival by sex - pregnancy status , age , WHO stage , CD4 + cell count at baseline , and country of enrollment .", "label": "", "metadata": {}, "score": "72.90112"}
{"text": "Eligible individuals were followed until the date last seen at a UK CHIC centre or the earliest of drop - out of follow - up for at least 18 months ; discontinuation of ART for at least 1 month ; transfer to a centre not providing laboratory data ; pregnancy .", "label": "", "metadata": {}, "score": "72.92601"}
{"text": "In sensitivity analyses , we excluded those with hepatitis B virus ( HBV ) or hepatitis C virus ( HCV ) coinfection and those who commenced nevirapine at CD4 + cell counts more than 350 cells / \u03bcl , as this is now contraindicated [ 17 ] .", "label": "", "metadata": {}, "score": "72.958855"}
{"text": "Although these results suggest that HIV patients living in areas with a high prevalence of tuberculosis should be thoroughly investigated for tuberculosis before ART initiation , current Indian guidelines do not have a protocol to rule out tuberculosis before starting ART ( 25 ) .", "label": "", "metadata": {}, "score": "73.02084"}
{"text": "This important study demonstrated how effective HAART was in clinical practice .Quoting from the abstract : .Mortality among the patients declined from 29.4 per 100 person - years in 1995 to 8.8 per 100 person - years in the second quarter of 1997 .", "label": "", "metadata": {}, "score": "73.02751"}
{"text": "British HIV Association guidelines for the management of HIV infection in pregnant women 2012 .HIV Med 2012 ; 13 ( Suppl 2):87 - 157 .", "label": "", "metadata": {}, "score": "73.0293"}
{"text": "Abrams EJ , Myer L , Rosenfield A , El - Sadr WM .Prevention of mother - to - child transmission services as a gateway to family - based human immunodeficiency virus care and treatment in resource - limited settings : rationale and international experiences .", "label": "", "metadata": {}, "score": "73.03604"}
{"text": "Rates of laboratory - defined adverse events .In 27 861 person - years of follow up , 1283 ( 13.6 % ) individuals experienced a LDAE .", "label": "", "metadata": {}, "score": "73.08017"}
{"text": "Weidle PJ , Wamai N , Solberg P , Liechty C , Sendagala S , Were W , et al .Adherence to antiretroviral therapy in a home - based AIDS care programme in rural Uganda .", "label": "", "metadata": {}, "score": "73.10625"}
{"text": "Collini P , Schwab U , Sarfo S , Obeng - Baah J , Norman B , Chadwick D , et al .Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort .", "label": "", "metadata": {}, "score": "73.19833"}
{"text": "Predictors of pregnancy and changes in pregnancy incidence among HIV - positive women accessing HIV clinical care .AIDS 2013 ; 27:95 - 103 .French CE , Cortina - Borja M , Thorne C , Tookey PA .", "label": "", "metadata": {}, "score": "73.30968"}
{"text": "Incident TB was defined as the first new clinical episode of TB diagnosed during ART for which the date of onset of overt symptoms occurred after ART initiation ; TB episodes were dated according to symptom onset .", "label": "", "metadata": {}, "score": "73.32292"}
{"text": "As of January 2007 , 1902 ( 85 % ) of the 2229 patients who initiated ART were alive and in active follow - up .", "label": "", "metadata": {}, "score": "73.48189"}
{"text": "Int J Epidemiol 2005 ; 34:979 - 986 .Djomand G , Roels T , Ellerbrock T , Hanson D , Diomande F , Monga B , et al .", "label": "", "metadata": {}, "score": "73.53601"}
{"text": "AIDS 2014 ; Feb 22 .[ Epub ahead of print].Danel C , Moh R , Minga A , Anzian A , Ba - Gomis O , Kanga C , et al .", "label": "", "metadata": {}, "score": "73.63004"}
{"text": "[ PMC free article ] [ PubMed ] .Kumarasamy N. Generic antiretroviral drugs - will they be the answer to HIV in the developing world ?", "label": "", "metadata": {}, "score": "73.68047"}
{"text": "AIDS 2003 ; 17(Suppl 3):S5-S15 .Fischer A , Karasi JC , KiRi D , Omes C , Lambert C , Uwayitu A , et al .", "label": "", "metadata": {}, "score": "73.7174"}
{"text": "Coria A , Noel F , Bonhomme J , Rouzier V , Perodin C , Marcelin A , et al .Consideration of postpartum management in HIV - positive Haitian women : an analysis of CD4 decline , mortality , and follow - up after delivery .", "label": "", "metadata": {}, "score": "73.75716"}
{"text": "Mother - to - child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort .AIDS 2008 ; 22:289 - 299 .Townsend CL , Byrne L , Cortina - Borja M , Thorne C , de Ruiter A , Lyall H , et al .", "label": "", "metadata": {}, "score": "73.868126"}
{"text": "Hammer et al .( 1996 )A trial comparing nucleoside monotherapy with combination therapy in HIV - infected adults with CD4 cell counts from 200 to 500 per cubic millimeter .", "label": "", "metadata": {}, "score": "74.10162"}
{"text": "Detailed structured clinical and laboratory records were maintained for every patient visit .Data were transferred on a weekly basis to an electronic database .Patients requiring hospital admission were referred to a nearby 200-bed facility .", "label": "", "metadata": {}, "score": "74.15302"}
{"text": "Trop Med Int Health 2008 ; 13 : 513 - 9 .[PubMed ] .Thompson MA , Aberg JA , Cahn P , Montaner JS , Rizzardini G , Telenti A , et al .", "label": "", "metadata": {}, "score": "74.177795"}
{"text": "Complete blood counts were provided with CD4 cell counts .Data analysis .The main outcome was a composite of severe AIDS associated morbidity and mortality ( referred to as severe morbidity and mortality ) .", "label": "", "metadata": {}, "score": "74.18184"}
{"text": "Model assumptions were evaluated and satisfied .Person - years of follow - up were calculated from the date of ART initiation to the date of program loss or last visit before data censoring .", "label": "", "metadata": {}, "score": "74.19317"}
{"text": "All person - time of observation accrued during treatment of prevalent TB present at baseline and during treatment of incident TB during ART was excluded .", "label": "", "metadata": {}, "score": "74.33563"}
{"text": "The remaining 1069 ( 72.2 % ) patients were alive and receiving ART at the time data were censored .Patients were followed up for a median of 2.1 years [ interquartile range ( IQR ) , 1.5 - 2.7 ; range , 1.0 - 4.5 years].", "label": "", "metadata": {}, "score": "74.37953"}
{"text": "In 2007 , only 12 % of HIV - positive pregnant women in antenatal care were assessed to determine if they were eligible to receive ART for their own health [ 1 ] .", "label": "", "metadata": {}, "score": "74.4047"}
{"text": "Baseline CD4 + cell count remained a strong predictor of CD4 + cell count over time on ART .At 6 months , the predicted CD4 + cell gain between the lowest baseline CD4 + cell count stratum ( 0 - 50 cells / \u03bcl ) and the highest CD4 + cell count stratum ( 201 - 350 cells / \u03bcl ) was 248 cells / \u03bcl .", "label": "", "metadata": {}, "score": "74.56195"}
{"text": "PLoS Med 2012 ; 9 : e1001245 .Alvarez - Uria G , Midde M , Pakam R , Naik PK .Gender differences , routes of transmission , socio - demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India .", "label": "", "metadata": {}, "score": "74.5677"}
{"text": "Moore AL , Mocroft A , Madge S , Devereux H , Wilson D , Phillips AN , Johnson M. Gender differences in virologic response to treatment in an HIV - positive population : a cohort study .", "label": "", "metadata": {}, "score": "74.67116"}
{"text": "Coviello V , Boggess M. Cumulative incidence estimation in the presence of competing risks .Stata J 2004 ; 4 : 103 - 12 .Fatti G , Meintjes G , Shea J , Eley B , Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community - based adherence support : 5-year results from a multicentre cohort study in South Africa .", "label": "", "metadata": {}, "score": "74.77226"}
{"text": "S.F. has received grants from NIH , Gates , BRC and MRC .M.J. has received honoraria and research funding from VIIV Healthcare , Janssen - Cilag , Abbvie , Gilead Sciences , BMS and MSD .", "label": "", "metadata": {}, "score": "74.84572"}
{"text": "10.1089/aid.2012.0028 CrossRef .ARTN e54665 CrossRef .Plos One Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa Gupta , A ; Wood , R ; Kaplan , R ; Bekker , LG ; Lawn , SD Plos One , 8(2 ) : - .", "label": "", "metadata": {}, "score": "74.91252"}
{"text": "Implementing strategies to provide social and economic support during the first year of ART could reduce the programme attrition because patients who were retained in care for 1 year were less likely to be LTFU ( 32 ) .", "label": "", "metadata": {}, "score": "75.00039"}
{"text": "2 .Cumulative incidence of ( A ) mortality and loss to follow up , ( B ) attrition by CD4 lymphocyte count , ( C ) mortality by CD4 lymphocyte count , and ( D ) loss to follow up by CD4 lymphocyte count .", "label": "", "metadata": {}, "score": "75.088684"}
{"text": "There were 2229 ART - naive individuals who initiated treatment by July 2006 and were included in this analysis ( Fig . 1 ) .Of these individuals , 1688 ( 76 % ) were women including 605 ( 36 % ) who were pregnant at ART initiation [ median gestational age 7 months , interquartile range ( IQR ) 6 - 8].", "label": "", "metadata": {}, "score": "75.100876"}
{"text": "XIX International AIDS Conference ( AIDS 2012 ) ; 2012 ; Washington , DC .Sabin CAC , David A. Collins , Simon ; Schechter , Mauro Rating evidence in treatment guidelines : a case example of when to initiate combination antiretroviral therapy ( cART ) in HIV - positive asymptomatic persons .", "label": "", "metadata": {}, "score": "75.127426"}
{"text": "Srikantiah P , Ghidinelli M , Bachani D , Chasombat S , Daoni E , Mustikawati DE , et al .Scale - up of national antiretroviral therapy programs : progress and challenges in the Asia Pacific region .", "label": "", "metadata": {}, "score": "75.15498"}
{"text": "Laurent C , Diakhate N , Gueye NF , Toure MA , Sow PS , Faye MA , et al .The Senegalese government 's highly active antiretroviral therapy initiative : an 18-month follow - up study .", "label": "", "metadata": {}, "score": "75.25884"}
{"text": "Of 1956 adults evaluated for enrolment , 1160 ( 59 % ) were eligible for ART and randomised to one of the three arms .Of these , 44 ( 4 % ) were excluded from analysis because they had previously received ART , leaving 368 in the viral load arm , 371 in the CD4 arm , and 377 in the clinical arm ( fig 1 \u200b 1 ) . )", "label": "", "metadata": {}, "score": "75.34603"}
{"text": "We also searched the electronic conference database of NLM Gateway , individual conference proceedings and prospective trials registers .We contacted researchers and relevant organizations and checked reference lists of all included studies .", "label": "", "metadata": {}, "score": "75.39811"}
{"text": "To protect your most sensitive data and activities ( like changing your password ) , we 'll ask you to re - enter your password when you access these services .", "label": "", "metadata": {}, "score": "75.442726"}
{"text": "In accordance with a South African study ( 22 ) , factors associated with mortality were similar to factors associated with LTFU .However , differences between predictors of mortality and LTFU were also found .", "label": "", "metadata": {}, "score": "75.557846"}
{"text": "[PubMed ] .Koenig SP , Kuritzkes DR , Hirsch MS , Leandre F , Mukherjee JS , Farmer PE , et al .Monitoring HIV treatment in developing countries .", "label": "", "metadata": {}, "score": "75.68634"}
{"text": "Kahn JO . et al .( 1992 )A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection .The NIAIDAIDS Clinical Trials Group .", "label": "", "metadata": {}, "score": "75.80693"}
{"text": "Coleman S , Boehmer U , Kanaya F , Grasso C , Tan J , Bradford J. Retention challenges for a community - based HIV primary care clinic and implications for intervention .", "label": "", "metadata": {}, "score": "75.82223"}
{"text": "Lawn SD , Myer L , Harling G , Orrell C , Bekker LG , Wood R. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa : implications for program evaluation .", "label": "", "metadata": {}, "score": "75.88899"}
{"text": "Designing programmes that maximise retention of patients and support adherence to treatment 22 31 32 33 might be more important than the use of laboratory monitoring , and many programmes in Africa have had default rates of 20 % or more , 34 suggesting potential for improvement .", "label": "", "metadata": {}, "score": "75.942024"}
{"text": "These findings highlight the urgent need to reduce the attrition after ART initiation of HIV infected patients in India .Starting ART at higher CD4 cell counts could have a major impact on reducing the mortality and LTFU after ART initiation .", "label": "", "metadata": {}, "score": "76.018394"}
{"text": "E.A. gave extensive editorial support and advised throughout the analysis .Dabis F , Balestre E , Braitstein P , Miotti P , Brinkhof WG , Schneider M , et al .", "label": "", "metadata": {}, "score": "76.14682"}
{"text": "Corbett EL , Bandason T , Cheung YB , Munyati S , Godfrey - Faussett P , Hayes R , et al .Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease .", "label": "", "metadata": {}, "score": "76.166626"}
{"text": "17 We did not find that quarterly viral loads provided additional clinical benefit to patients .This could have been because of limited statistical power in our study .", "label": "", "metadata": {}, "score": "76.262634"}
{"text": "HIV Med 2008 ; 9:563 - 608 .Williams I , Churchill D , Anderson J , Boffito M , Bower M , Cairns G , et al .", "label": "", "metadata": {}, "score": "76.3313"}
{"text": "HIV Med 2006 ; 7:64 - 66 .Frater AJ , Dunn DT , Beardall AJ , Ariyoshi K , Clarke JR , McClure MO , Weber JN .", "label": "", "metadata": {}, "score": "76.352264"}
{"text": "Laboratory adverse events and discontinuation of therapy according to CD4 + cell count at the start of antiretroviral therapy .f Kings College Hospital NHS Foundation Trust and King 's College London .", "label": "", "metadata": {}, "score": "76.4897"}
{"text": "Figure 1 presents a stacked graph of the status of HIV patients since ART initiation .The cumulative incidence of attrition , mortality , and LTFU after 6 months , 1 year , 2 years , 3 years , 4 years , and 5 years of follow - up is presented in Table 2 .", "label": "", "metadata": {}, "score": "76.71916"}
{"text": "Palella et al .( 1998 )Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection .New England Journal of Medicine .", "label": "", "metadata": {}, "score": "76.78502"}
{"text": "3 C ) .Fig .3 .( A ) Attrition , ( B ) mortality , and ( C ) loss to follow up by the timing of tuberculosis diagnosis .", "label": "", "metadata": {}, "score": "76.91995"}
{"text": "As steering committee members for participating centres , P.H. , F.A.P. , R.G. , M.N. , M.G. , M.F. , M.J. , D.C. , C.L. advised on study concept and critically reviewed the analysis .", "label": "", "metadata": {}, "score": "77.03598"}
{"text": "Obstet Gynecol 1997 ; 89:967 - 974 .Ekouevi DK , Inwoley A , Tonwe - Gold B , Danel C , Becquet R , Viho I , et al .", "label": "", "metadata": {}, "score": "77.10193"}
{"text": "HIV Med 2004 ; 5:115 - 124 .Stern JO , Robinson PA , Love J , Lanes S , Imperiale MS , Mayers DL .", "label": "", "metadata": {}, "score": "77.103226"}
{"text": "5 6 A smaller proportion provide routine viral load testing .High viral load and low CD4 cell count are independently associated with mortality , 9 10 11 and changes in viral load and CD4 cell count during treatment have been associated with survival .", "label": "", "metadata": {}, "score": "77.20082"}
{"text": "Alvarez - Uria G , Midde M , Pakam R , Kannan S , Bachu L , Naik PK .Factors associated with late presentation of HIV and estimation of antiretroviral treatment need according to CD4 lymphocyte count in a resource - limited setting : data from an HIV cohort study in India .", "label": "", "metadata": {}, "score": "77.3598"}
{"text": "Franke MF , Kaigamba F , Socci AR , Hakizamungu M , Patel A , Bagiruwigize E , et al .Improved retention associated with community - based accompaniment for antiretroviral therapy delivery in rural Rwanda .", "label": "", "metadata": {}, "score": "77.47329"}
{"text": "In addition , the analysis was performed considering all discontinuations occurring after ART initiation ( including those in the first year ) but restricting to the few centres that had no involvement in the SPARTAC study .", "label": "", "metadata": {}, "score": "77.596855"}
{"text": "Black V , Hoffman RM , Sugar CA , Menon P , Venter F , Currier JS , Rees H. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg , South Africa .", "label": "", "metadata": {}, "score": "77.63709"}
{"text": "[PubMed ] .Reynolds SJ , Kityo C , Mbamanya F , Ndyanabo A , Galiwongo R , Boaz I , et al .Evolution of drug resistance after virological failure of a first - line highly active antiretroviral therapy regimen in Uganda .", "label": "", "metadata": {}, "score": "77.892166"}
{"text": "JAMA 1999 ; 282:2220 - 2226 .Kirk O , Gatell JM , Mocroft A , Pedersen C , Proenca R , Brettle RP , et al .", "label": "", "metadata": {}, "score": "78.02888"}
{"text": "The high mortality of patients LTFU may explain the similarities between the predictors of mortality and LTFU found in our study .Those variables related to LTFU , but not to mortality ( i.e. younger age , being single , illiteracy , and not living near an ART centre ) , may be useful to identify patients with a lower risk of death among those LTFU .", "label": "", "metadata": {}, "score": "78.10059"}
{"text": "Results : After 5 years of follow - up , the estimated cumulative incidence of attrition was 37.7 % .There was no significant difference between attrition due to mortality and attrition due to LTFU .", "label": "", "metadata": {}, "score": "78.30052"}
{"text": "Tuomala RE , Kalish LA , Zorilla C , Fox H , Shearer W , Landay A , et al .Changes in total , CD4 + , and CD8 + lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus - infected women .", "label": "", "metadata": {}, "score": "78.33104"}
{"text": "P.A.T. is the guarantor .The work was undertaken at the Centre for Paediatric Epidemiology and Biostatistics ( now Population , Policy and Practice ) , which benefitted from funding support from the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health ( grant number G0400546 ) .", "label": "", "metadata": {}, "score": "78.43409"}
{"text": "Martin et al .[29 ] reported an average increase of 133 cells / \u03bcl after 33 months of follow - up in a cohort of pregnant women in London .", "label": "", "metadata": {}, "score": "78.435684"}
{"text": "[PubMed ] .DART Virology Group and Trial Team .Virological response to a triple nucleoside / nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa .", "label": "", "metadata": {}, "score": "78.49676"}
{"text": "Study population .Patients transferred to other ART centres after initiating ART were not included in the analysis .The selection of patients from the database was executed on 14 September 2012 ( end of the study period ) .", "label": "", "metadata": {}, "score": "78.617294"}
{"text": "W.E.-S. edited the manuscript and gave input throughout the writing process .L.M. edited the manuscript and gave specific input into issues of HIV treatment during pregnancy .", "label": "", "metadata": {}, "score": "78.62909"}
{"text": "[PubMed ] .Stringer JS , Zulu I , Levy J , Stringer EM , Mwango A , Chi BH , et al .Rapid scale - up of antiretroviral therapy at primary care sites in Zambia : feasibility and early outcomes .", "label": "", "metadata": {}, "score": "78.64039"}
{"text": "National surveillance of obstetric and paediatric HIV is undertaken through the National Study of HIV in Pregnancy and Childhood in collaboration with Public Health England ( formerly the Health Protection Agency ) and Health Protection Scotland .", "label": "", "metadata": {}, "score": "78.66182"}
{"text": "Clin Infect Dis 2007 ; 44 : 128 - 34 .[PubMed ] .Mugyenyi P , Walker AS , Hakim J , Munderi P , Gibb DM , Kityo C , et al .", "label": "", "metadata": {}, "score": "78.71358"}
{"text": "Of particular importance , the CD4 cell count threshold above which TB rates are minimized during ART - induced immune recovery is not known .To address these questions , we analysed data collected prospectively over 4.5 years of follow - up of a large ART cohort in Cape Town , South Africa .", "label": "", "metadata": {}, "score": "78.75493"}
{"text": "Interaction terms were included to assess whether any associations changed over time .In order to test the consistency of potential effects of country of enrollment on CD4 + cell count response , country of enrollment was considered as a fixed - effect covariate .", "label": "", "metadata": {}, "score": "78.755264"}
{"text": "Int J Tuberc Lung Dis 2000 ; 4:1026 - 1031 .Santoro - Lopes G , de Pinho AM , Harrison LH , Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy .", "label": "", "metadata": {}, "score": "78.76919"}
{"text": "I do not ... . ... your HIV viral load is .Given the likely stress of an eating disorder on your immune system , you may see a small improvement in CD4 count now .", "label": "", "metadata": {}, "score": "78.85751"}
{"text": "5 years .CI , confidence interval .Figure 2 presents the cumulative incidence of attrition , mortality , and LTFU stratified by CD4 cell counts .", "label": "", "metadata": {}, "score": "78.91995"}
{"text": "Design : We describe factors associated with attrition , mortality , and LTFU in 3,159 HIV infected patients who initiated ART between 1 January 2007 and 4 November 2011 in an HIV cohort study in India .", "label": "", "metadata": {}, "score": "79.03236"}
{"text": "World Health Organization .Improving the diagnosis and treatment of smear - negative pulmonary and extra - pulmonary tuberculosis among adults and adolescents .Recommendations for HIV - prevalent and resource - constrained settings .", "label": "", "metadata": {}, "score": "79.1551"}
{"text": "Demographic and clinical parameters were similar across study arms , except that fewer women were enrolled in the clinical arm ( table 1 \u200b 1 ) .", "label": "", "metadata": {}, "score": "79.16858"}
{"text": "PubMed ] .Moore D , Awor A , Downing R , Were W , Behumbiize P , Mermin J. Evaluation of immunologic monitoring to identify patients with virologic failure after initiation of antiretroviral therapy in rural Uganda .", "label": "", "metadata": {}, "score": "79.20843"}
{"text": "I have had HIV since November 2008 and 3 - 4 months later am undetectable with CD4 Count in the 200 's but my last CD4 count in January 2010 is in the 300 's .", "label": "", "metadata": {}, "score": "79.21054"}
{"text": "Results : Two hundred and three cases of TB were diagnosed during 2785 person - years of observation ( overall incidence , 7.3 cases/100 person - years ) .", "label": "", "metadata": {}, "score": "79.26343"}
{"text": "[PubMed ] .Lai TL , Shih MC , Zhu G. Modified Haybittle - Peto group sequential designs for testing superiority and non - inferiority hypotheses in clinical trials .", "label": "", "metadata": {}, "score": "79.339264"}
{"text": "ARTN e9611 CrossRef .Lancet Tuberculosis 3 The HIV - associated tuberculosis epidemic - when will we act ?Harries , AD ; Zachariah , R ; Corbett , EL ; Lawn , SD ; Santos , ET ; Chimzizi , R ; Harrington , M ; Maher , D ; Williams , BG ; De Cock , KM Lancet , 375 ( ) : 1906 - 1919 .", "label": "", "metadata": {}, "score": "79.49443"}
{"text": "However , some epidemiological studies suggest a more generalised distribution of HIV in the population ( 4 - 7 ) .By December 2012 , 1.7 million people living with HIV had been registered in Government ART centres , of whom 604,987 had started ART under the national programme ( 8 ) .", "label": "", "metadata": {}, "score": "79.50589"}
{"text": "Lancet 2006 ; 367:1981 - 1989 .World Health Organization .Programmatic update .Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants .", "label": "", "metadata": {}, "score": "79.5712"}
{"text": "[PubMed ] .Ferradini L , Jeannin A , Pinoges L , Izopet J , Odhiambo D , Mankhambo L , et al .Scaling up of highly active antiretroviral therapy in a rural district of Malawi : an effectiveness assessment .", "label": "", "metadata": {}, "score": "79.59214"}
{"text": "Deaths and losses to follow - up were ascertained by active community - based follow - up as previously described [ 25 ] .Collection of data on this study population for research purposes was approved by the Research Ethics Committee of the University of Cape Town and all patients enrolled gave written informed consent .", "label": "", "metadata": {}, "score": "79.61315"}
{"text": "[PubMed ] .Wools - Kaloustian K , Kimaiyo S , Diero L , Siika A , Sidle J , Yiannoutsos CT , et al .", "label": "", "metadata": {}, "score": "79.64205"}
{"text": "Concorde Coordinating Committee ( 1994 ) .MRC / ANRS randomised double - blind controlled trial of immediate and deferred zidovudine in symptom - free HIV infection .", "label": "", "metadata": {}, "score": "79.698524"}
{"text": "A data safety monitoring board reviewed data every three months and was asked to reject the null hypothesis of monitoring arm equivalence if the rate of severe morbidity and mortality in any arm exceeded another by three standard errors of the difference ( \" Haybittle - Peto \" rule ) .", "label": "", "metadata": {}, "score": "79.78845"}
{"text": "AIDS Res Hum Retroviruses 2007 ; 23:1469 - 1474 .Lebon A , Bland RM , Rollins NC , Coutsoudis A , Coovadia H , Newell ML .", "label": "", "metadata": {}, "score": "80.46742"}
{"text": "Moore D , Liechty C , Ekwaru P , Were W , Mwima G , Solberg P , et al .Prevalence , incidence and mortality associated with tuberculosis in HIV - infected patients initiating antiretroviral therapy in rural Uganda .", "label": "", "metadata": {}, "score": "80.51724"}
{"text": "Read more \" . ...I have had HIV since November 2008 and 3 - 4 months later am undetectable with CD4 Count in the 200 's but my last CD4 count in January 2010 is in the 300 's .", "label": "", "metadata": {}, "score": "80.63214"}
{"text": "Clin Infect Dis 2006 ; 42 : 136 - 44 .[PubMed ] .Weidle PJ , Malamba S , Mwebaze R , Sozi C , Rukundo G , Downing R , et al .", "label": "", "metadata": {}, "score": "80.63659"}
{"text": "Increasing Cd4 Count .my recieved first lab results and found out my CD4 count is 366 . 1 year prior to my diagnosis and 1st labs I became anorexic / bullimic .", "label": "", "metadata": {}, "score": "80.66135"}
{"text": "Dalal RP , Macphail C , Mqhayi M , Wing J , Feldman C , Chersich MF , Venter WD .Characteristics and outcomes of adult patients lost to follow - up at an antiretroviral treatment clinic in Johannesburg , South Africa .", "label": "", "metadata": {}, "score": "80.81415"}
{"text": "1992 Aug 27;327(9):581 - 7 We include this study to debunk a denialist lie that didanosine was registered by the US Food and Drug Administration ( FDA ) without a clinical trial being conducted .", "label": "", "metadata": {}, "score": "80.85141"}
{"text": "Lawn SD , Myer L , Bekker LG , Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub - Saharan Africa : impact on treatment outcomes and implications for tuberculosis control .", "label": "", "metadata": {}, "score": "80.953735"}
{"text": "Results 1094 participants started ART ; median CD4 count at baseline was 129 cells \u00d7 10 6 /L. Median follow - up was three years .", "label": "", "metadata": {}, "score": "81.11224"}
{"text": "The incidence of any of three major opportunistic infections ( Pneumocystis carinii pneumonia , Mycobacterium avium complex disease , and cytomegalovirus retinitis ) declined from 21.9 per 100 person - years in 1994 to 3.7 per 100 person - years by mid-1997 .", "label": "", "metadata": {}, "score": "81.19139"}
{"text": "Bakeera - Kitaka A , Dhabangi A , Namulema E , Maganda A , Boulware DR .Immune reconstitution inflammatory syndrome and postantiretroviral tuberculosis among HIV - infected Ugandan children .", "label": "", "metadata": {}, "score": "81.36582"}
{"text": "Overall retention in care was high : 82 % for pregnant women , 86 % for men , and 87 % of nonpregnant women at 30 months of follow - up .", "label": "", "metadata": {}, "score": "81.44656"}
{"text": "Read more \" . ... allele are at risk of having reduced corpus callosum volume , which means atrophy of the corpus callosum if they have low nadir CD4 counts .", "label": "", "metadata": {}, "score": "81.44929"}
{"text": "Ross A , Van der Paal L , Lubega R , Mayanja BN , Shafer LA , Whitworth J. HIV-1 disease progression and fertility : the incidence of recognized pregnancy and pregnancy outcome in Uganda .", "label": "", "metadata": {}, "score": "81.469055"}
{"text": "M.F. has received funding from Gilead , BMS , Viiv , Abbott , Janssen and Merck in connection with project grants , speakers fees and conference attendance .", "label": "", "metadata": {}, "score": "81.53568"}
{"text": "Lancet 2010 ; 375 : 123 - 31 .[ PMC free article ] [ PubMed ] .World Health Organization .Antiretroviral therapy for HIV infection in adults and adolescents in resource - limited settings : recommendations towards a public health approach .", "label": "", "metadata": {}, "score": "81.539764"}
{"text": "15 16 17 A recently reported randomised clinical trial examining different monitoring strategies for individuals receiving ART found only marginal clinical benefits in terms of mortality associated with providing six monthly monitoring of CD4 cell count in addition to clinical monitoring in Uganda and Zimbabwe .", "label": "", "metadata": {}, "score": "81.674805"}
{"text": "\" Some epidemiological evidence suggests that HIV - infected patients remain healthier when they begin treatment at higher CD4 counts .START will be conducted in 30 countries .", "label": "", "metadata": {}, "score": "81.70863"}
{"text": "10.5588/ijtld.12.0314 CrossRef .International Journal of Tuberculosis and Lung Disease Data needs for evidence - based decisions : a tuberculosis modeler 's ' wish list ' Dowdy , DW ; Dye , C ; Cohen , T International Journal of Tuberculosis and Lung Disease , 17(7 ) : 866 - 877 .", "label": "", "metadata": {}, "score": "81.71628"}
{"text": "[ 8,9 ] .Pregnancy incidence among HIV - positive women in the UK is increasing [ 10 ] , partly driven by the growing number of women having repeat pregnancies [ 11 ] .", "label": "", "metadata": {}, "score": "81.71977"}
{"text": "Gandhi NR , Moll A , Sturm AW , Pawinski R , Govender T , Lalloo U , et al .Extensively drug - resistant tuberculosis as a cause of death in patients co - infected with tuberculosis and HIV in a rural area of South Africa .", "label": "", "metadata": {}, "score": "82.00562"}
{"text": "J Infect Dis 2008 ; 197 : 1145 - 55 .[PubMed ] .Phillips AN , Pillay D , Miners AH , Bennett DE , Gilks CF , Lundgren JD .", "label": "", "metadata": {}, "score": "82.21701"}
{"text": "Reynolds SJ , Nakigozi G , Newell K , Ndyanabo A , Galiwongo R , Boaz I , et al .Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda .", "label": "", "metadata": {}, "score": "82.21947"}
{"text": "van der Merwe K , Chersich MF , Technau K , Umurungi Y , Conradie F , Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province , South Africa .", "label": "", "metadata": {}, "score": "82.403366"}
{"text": "Seyler C , Toure S , Messou E , Bonard D , Gabillard D , Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan .", "label": "", "metadata": {}, "score": "82.53138"}
{"text": "The numbers were not looking very good - 330/3104 .While the viral load was low , the CD4 count was low also .My doctor was concerned , and told me to get another CD4 count down asap and see him in 3 weeks ...", "label": "", "metadata": {}, "score": "82.534485"}
{"text": "Trop Med Int Health Jul 2008 ; 13 : 870 - 9 .[PubMed ] .Kamya MR , Mayanja - Kizza H , Kambugu A , Bakeera - Kitaka S , Semitala F , Mwebaze - Songa P , et al .", "label": "", "metadata": {}, "score": "82.5571"}
{"text": "Mocroft et al .( 2003 ) Decline in the AIDS and death rates in the EuroSIDA study : an observational study .Lancet .2003 Jul 5;362(9377):22 - 9 .", "label": "", "metadata": {}, "score": "82.57566"}
{"text": "Patients who did not die during the study period were censored at their last visit to the clinics .Patients who did not come to the clinics for at least 180 days after their last scheduled appointment were considered LTFU ( 18 ) .", "label": "", "metadata": {}, "score": "82.75769"}
{"text": "The median time from the first CD4 cell count to initiation of ART was 28 days ( 22 - 37 ) .Table 2 \u200b 2 shows the time to first event analysis , with an intention to treat approach from the time of initiation of ART .", "label": "", "metadata": {}, "score": "82.819466"}
{"text": "Bilirubin was not considered a LDAE so as to exclude atazanavir - induced hyperbilirubinaemia .ART discontinuation was defined as stopping all ART for at least 1 month .", "label": "", "metadata": {}, "score": "82.867645"}
{"text": "Weidle PJ , Malamba S , Mwebaze R , Sozi C , Rukundo G , Downing R , et al .Assessment of a pilot antiretroviral drug therapy programme in Uganda : patients ' response , survival , and drug resistance .", "label": "", "metadata": {}, "score": "82.886566"}
{"text": "On January 25th , 2009 I was diagnosed as HIV positive and classified an AIDS patient .They told me my CD4 count was 5 .", "label": "", "metadata": {}, "score": "82.90021"}
{"text": "The main study group consisted of 1177 pregnancies to women not on treatment at conception ; 1063 resulted in a live or stillbirth .Most ( 76.0 % ) were in women from sub - Saharan Africa , median age was 30.3 years [ interquartile range ( IQR ) 26.9 - 33.8 ] , and 43.4 % occurred during 2008 - 2010 .", "label": "", "metadata": {}, "score": "82.92023"}
{"text": "The HIV epidemic in India has been considered concentrated in high - risk groups ( female sex workers , men who have sex with men , transgender , and injecting drug users ) who transmit the virus to the general population through a bridge population ( male migrants and truckers ) .", "label": "", "metadata": {}, "score": "82.93469"}
{"text": "Alvarez - Uria G , Naik PK , Pakam R , Bachu L , Midde M. Natural history and factors associated with early and delayed mortality in HIV infected patients treated of tuberculosis under directly observed treatment short course ( DOTS ) strategy : a prospective cohort study in India .", "label": "", "metadata": {}, "score": "82.937"}
{"text": "Mtei L , Matee M , Herfort O , Bakari M , Horsburgh CR , Waddell R , et al .High rates of clinical and subclinical tuberculosis among HIV - infected ambulatory subjects in Tanzania .", "label": "", "metadata": {}, "score": "82.96705"}
{"text": "Comparison with other studies .Our results are largely consistent with those of the Development of Antiretroviral Therapy for Africa ( DART ) trial , which was recently completed in two sites in Uganda and one in Zimbabwe , 18 although we differ somewhat in our interpretation of these results .", "label": "", "metadata": {}, "score": "82.98926"}
{"text": "Ethics statement .The study was approved by the Ethical Committee of the Rural Development Trust Hospital .Written informed consent was given by patients or caretakers for their information to be stored in the study database and used for research .", "label": "", "metadata": {}, "score": "83.06747"}
{"text": "Bekker LG , Myer L , Orrell C , Lawn S , Wood R. Rapid scale - up of a community - based HIV treatment service : programme performance over 3 consecutive years in Guguletu , South Africa .", "label": "", "metadata": {}, "score": "83.078995"}
{"text": "Bekker LG , Myer L , Orrell C , Lawn S , Wood R. Rapid scale - up of a community - based HIV treatment service : programme performance over 3 consecutive years in Guguletu , South Africa .", "label": "", "metadata": {}, "score": "83.078995"}
{"text": "Lancet 2002 ; 360 : 34 - 40 .[PubMed ] .Braitstein P , Brinkhof MW , Dabis F , Schechter M , Boulle A , Miotti P , et al .", "label": "", "metadata": {}, "score": "83.75536"}
{"text": "AIDS denialists have claimed that the Concorde trial supports the view that the risks of AZT outweigh its benefits .This is false .Concorde was the biggest AZT monotherapy study over the longest period of time .", "label": "", "metadata": {}, "score": "83.83966"}
{"text": "Clin Infect Dis 2009 ; 49 : 1928 - 35 .[ PMC free article ] [ PubMed ] .Kahn JG , Marseille E , Moore D , Bunnell R , Were W , Degerman R , et al .", "label": "", "metadata": {}, "score": "83.88451"}
{"text": "WHO guidelines provide flexible recommendations for monitoring people taking ART .19 We initiated a randomised clinical trial in Uganda to empirically evaluate whether routine monitoring of viral loads and CD4 cell count provides clinical benefits to individuals receiving ART in sub - Saharan Africa .", "label": "", "metadata": {}, "score": "84.22768"}
{"text": "Definitions .Designation of the community of patients was performed by self - identification .Scheduled caste community is marginalised in the traditional Hindu caste hierarchy and , therefore , suffers social and economic exclusion and disadvantage ( 16 ) .", "label": "", "metadata": {}, "score": "84.52056"}
{"text": "S.J. , T.H. , K.Q. and C.L. have no conflicts of interest to declare .J.W. has received funds from Gilead sciences in connection with conference attendance .", "label": "", "metadata": {}, "score": "84.71869"}
{"text": "The Cameroon program had been operational for less than 1 year and the Mozambique site did not report data for the entire study period .Women who received short - course PMTCT antiretroviral drugs ( i.e. SD - NVP or short - course zidovudine ( ZDV )", "label": "", "metadata": {}, "score": "84.846405"}
{"text": "Specimens with discordant results were retested with the same algorithm and , if still discordant , by western blotting ( LAV Blot , Biorad , Richmond , VA ) .", "label": "", "metadata": {}, "score": "85.02072"}
{"text": "Data collection and analysis Two review authors independently assessed study eligibility , extracted data , and graded methodological quality .Data extraction and methodological quality were checked by a third author who resolved differences when these arose .", "label": "", "metadata": {}, "score": "85.057"}
{"text": "C.E.F. conceived the study with input from the other authors .C.E.F. conducted the analyses , with support from M.C.-B. , and drafted the paper .", "label": "", "metadata": {}, "score": "85.16467"}
{"text": "JM is guarantor .Funding :This study was funded by the US Centers for Disease Control and Prevention , the US Agency for International Development , and the President 's Emergency Plan for AIDS Relief .", "label": "", "metadata": {}, "score": "85.29473"}
{"text": "Participants were weighed each month during home visits and these weights and body mass index ( BMI ) scores were provided to clinicians .After enrolment , no routine clinic visits were scheduled but participants were encouraged to come to the clinic or hospital if they were ill and were transported to the clinic for assessment if they had specifically defined symptoms or severe illness during a home visit .", "label": "", "metadata": {}, "score": "85.405914"}
{"text": "Pulmonary tuberculosis was defined as positive results for acid fast bacilli during microscopy from two sputum smears or negative results from sputum smears but with chest radiography compatible with tuberculosis and a lack of response to a two week trial of antibiotics .", "label": "", "metadata": {}, "score": "85.43041"}
{"text": "+1 212 342 0541 ; fax :+1 212 342 1824 ; e - mail : plt9@columbia.edu .Abstract .Objective(s ) : Few data are available from resource - limited countries on long - term outcomes of HIV - infected women who initiate antiretroviral therapy ( ART ) during pregnancy .", "label": "", "metadata": {}, "score": "85.55371"}
{"text": "With responsible implementation , ART is a key component of a comprehensive response to the epidemic in those communities most affected by HIV .\"Cape Town , South Africa Cohort .", "label": "", "metadata": {}, "score": "85.70531"}
{"text": "M.N. has received funding from Merck , Viiv , Gilead , Viiv and Abbott in connection with project grants , consultancy , speakers fees , conference attendance and preparation of educational materials .", "label": "", "metadata": {}, "score": "85.97386"}
{"text": "[PubMed ] .Chang LW , Alamo S , Guma S , Christopher J , Suntoke T , Omasete R , et al .Two - year virologic outcomes of an alternative AIDS care model : evaluation of a peer health worker and nurse - staffed community - based program in Uganda .", "label": "", "metadata": {}, "score": "86.012344"}
{"text": "The denialists misrepresent the following about the Concorde trial : In a long - term follow up of the Concorde patients those who deferred AZT treatment until they got AIDS were less likely ( slightly , but statistically significantly ) to die than those who took it immediately .", "label": "", "metadata": {}, "score": "86.20986"}
{"text": "Cited By : .This article has been cited 3 time(s ) .10.1093/cid / cis858 CrossRef .10.1016/j.jana.2011.12.007 CrossRef .ARTN 17994 CrossRef .", "label": "", "metadata": {}, "score": "86.24655"}
{"text": "The aim of this study is to describe the attrition after ART initiation in a large cohort of patients in Anantapur , India .Methods .", "label": "", "metadata": {}, "score": "86.285965"}
{"text": "Coetzee et al .( 2004 )Outcomes after two years of providing antiretroviral treatment in Khayelitsha , South Africa .AIDS April 9 , 2004 , 18:6 .", "label": "", "metadata": {}, "score": "86.337944"}
{"text": "Hoffman RM , Black V , Technau K , van der Merwe KJ , Currier J , Coovadia A , et al .Effects of highly active antiretroviral therapy duration and regimen on risk for mother - to - child transmission of HIV in Johannesburg , South Africa .", "label": "", "metadata": {}, "score": "86.66077"}
{"text": "Results : Of 2229 individuals initiating ART , 1688 were women , of which 605 were pregnant ( median gestational age 7 months ) , 1083 were not pregnant , and 541 were men .", "label": "", "metadata": {}, "score": "86.864044"}
{"text": "The higher risk of death of people living in rural areas is probably related to poorer access to medical care in rural areas of India ( 33 ) .", "label": "", "metadata": {}, "score": "86.96327"}
{"text": "Hi , I was diagnosed with HIV around 15 months ago .Since then my health has been good ( especially in the last six months ) but my CD4 count has fallen a bit rapidly from 470 to 371 to 324 over this time period .", "label": "", "metadata": {}, "score": "87.11981"}
{"text": "BMJ 2011 ; 343 : d6884 [ PMC free article ] [ PubMed ] .Chen SC , Yu JK , Harries AD , Bong CN , Kolola - Dzimadzi R , Tok TS , et al .", "label": "", "metadata": {}, "score": "87.12039"}
{"text": "[ PMC free article ] [ PubMed ] .Egger M , May M , Chene G , Phillips AN , Ledergerber B , Dabis F , et al .", "label": "", "metadata": {}, "score": "87.83469"}
{"text": "Patients LTFU may not be lost forever because they may reengage in the future or enrol in other ART centres .However , in a systematic review and meta - analysis of the mortality of patients LTFU in sub - Saharan Africa , it was estimated that the mortality of patients LTFU can be nearly 50 % in programmes with a 20 % rate of LTFU ( 30 ) .", "label": "", "metadata": {}, "score": "87.97922"}
{"text": "The mortality rate after 90 days was lower ( 1.99/100 child - years , 95%CI 1.55 to 2.55 ) .Rates of loss to follow - up ( 6 % ) and transfer to other services ( 5 % ) were low .", "label": "", "metadata": {}, "score": "88.10527"}
{"text": "In Bathalapalli RDT Hospital , CD4 count enumeration and ART are provided free of charge by the Indian Government under a public - private partnership .", "label": "", "metadata": {}, "score": "88.33217"}
{"text": "Male partners and other household members of index women , if HIV - infected , were eligible for enrollment , as were their HIV - exposed and infected children .", "label": "", "metadata": {}, "score": "88.42982"}
{"text": "Kleinbaum DG , Klein M. Survival analysis , a self - learning text .Second .New York , USA : Springer ; 2005 .Royston P. Multiple imputation of missing values : further update of ice , with an emphasis on categorical variables .", "label": "", "metadata": {}, "score": "88.62518"}
{"text": "Statistical analysis was performed using Stata Statistical Software ( Stata Corporation .Release 11 .College Station , TX , USA ) .To investigate predictors of attrition , time - to - event methods were used .", "label": "", "metadata": {}, "score": "88.85741"}
{"text": "Chi BH , Yiannoutsos CT , Westfall AO , Newman JE , Zhou J , Cesar C , et al .Universal definition of loss to follow - up in HIV treatment programs : a statistical analysis of 111 facilities in Africa , Asia , and Latin America .", "label": "", "metadata": {}, "score": "88.89327"}
{"text": "The study was performed in Anantapur , a district situated in the State of Andhra Pradesh , India .The HIV epidemic in Anantapur is largely driven by heterosexual transmission , and it is characterised by poor socio - economic conditions and high levels of illiteracy ( 6 ) .", "label": "", "metadata": {}, "score": "88.986626"}
{"text": "JAMA 2010 ; 304 : 321 - 33 .[PubMed ] .World Health Organization .Towards universal access : scaling up priority HIV / AIDS interventions in the health sector : progress report , June 2008 .", "label": "", "metadata": {}, "score": "89.019485"}
{"text": "By checking this box , you 'll stay logged in until you logout .You 'll get easier access to your articles , collections , media , and all your other content , even if you close your browser or shut down your computer .", "label": "", "metadata": {}, "score": "89.16286"}
{"text": "The mean weight - for - age z - score rose from -2.42 ( 95%CI -2.50 to -2.33 ) at ART initiation , to -0.67 ( 95%CI -0.87 to -0.46 ) at 42 months .", "label": "", "metadata": {}, "score": "89.19688"}
{"text": "Concorde only examined people with HIV WITHOUT symptoms of AIDS .It compared two strategies : Approximately half the trial participants took AZT immediately and the other half took placebo UNTIL they developed AIDS .", "label": "", "metadata": {}, "score": "89.561226"}
{"text": "Data were entered with Epi Info ( CDC , Atlanta , GA ) and analysed with SAS 9.0 ( SAS Institute , Cary , NC ) .", "label": "", "metadata": {}, "score": "89.863464"}
{"text": "Contributors : DMM , RB , AC , PS , JC , JT , and JM were principal investigators during the study and were involved in writing protocols and/or supervising study implementation , interpreting data , and editing the manuscript .", "label": "", "metadata": {}, "score": "90.06363"}
{"text": "One recent mathematical model showed little benefit and considerable cost even during 20 years of follow - up .12 Furthermore , programmes in Haiti 13 and Malawi 14 have reported treatment success with clinical monitoring alone , although no groups with laboratory monitoring were available for comparison .", "label": "", "metadata": {}, "score": "90.107445"}
{"text": "[ PMC free article ] [ PubMed ] .Hoffmann CJ , Charalambous S , Sim J , Ledwaba J , Schwikkard G , Chaisson RE , et al .", "label": "", "metadata": {}, "score": "90.18338"}
{"text": "4 .Cox regression analysis of factors associated with attrition ( mortality or loss to follow up ) , mortality , and loss to follow up .", "label": "", "metadata": {}, "score": "90.22866"}
{"text": "San Diego , California , USA ; October 2007 .Lawn SD , Bekker LG , Middelkoop K , Myer L , Wood R. Impact of HIV infection on the epidemiology of tuberculosis in a peri - urban community in South Africa : the need for age - specific interventions .", "label": "", "metadata": {}, "score": "90.4052"}
{"text": "[ PMC free article ] [ PubMed ] .Calmy A , Ford N , Hirschel B , Reynolds SJ , Lynen L , Goemaere E , et al .", "label": "", "metadata": {}, "score": "90.408356"}
{"text": "[ PMC free article ] [ PubMed ] .Brigido L , Rodrigues R , Casseb J , Custodio RM , Fonseca LA , Sanchez M , et al .", "label": "", "metadata": {}, "score": "90.442825"}
{"text": "These intervals were categorized into CD4 cell count strata ( CD4 cell strata ) 0 - 100 , 101 - 200 , 201 - 300 , 301 - 400 , 401 - 500 and more than 500 cells / \u03bcl .", "label": "", "metadata": {}, "score": "90.87508"}
{"text": "Short - term and long - term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa .Author Information . a The Desmond Tutu HIV Centre , Institute for Infectious Disease and Molecular Medicine , Faculty of Health Sciences , University of Cape Town , Cape Town , South Africa .", "label": "", "metadata": {}, "score": "91.028534"}
{"text": "In line with two South African studies ( 22 , 29 ) , attrition was more common during the first year of follow - up .", "label": "", "metadata": {}, "score": "91.44002"}
{"text": "Spacek LA , Shihab HM , Kamya MR , Mwesigire D , Ronald A , Mayanja H , et al .Response to antiretroviral therapy in HIV - infected patients attending a public , urban clinic in Kampala , Uganda .", "label": "", "metadata": {}, "score": "92.26608"}
{"text": "However research studies investigating predictors of mortality or loss to follow up ( LTFU ) after ART initiation are scarce in India ( 10 ) .", "label": "", "metadata": {}, "score": "92.58657"}
{"text": "The authors gratefully acknowledge the dedicated staff of the Hannan Crusaid ART clinic and the Desmond Tutu HIV Centre .References .Ledergerber B , Egger M , Erard V , Weber R , Hirschel B , Furrer H , et al .", "label": "", "metadata": {}, "score": "92.728325"}
{"text": "Multivariable analysis was performed by Cox regression proportional hazard models .The proportional hazard assumption was assessed performing log - log survival curves based on Schoenfeld residuals ( 19 ) .", "label": "", "metadata": {}, "score": "92.805016"}
{"text": "In other analyses , Fisher 's exact and Wilcoxon rank - sum tests were used to compare proportions and medians , respectively , and all statistical tests are two - sided at \u03b1 value of 0.05 .", "label": "", "metadata": {}, "score": "93.369064"}
{"text": "The variables that were imputed were poverty ( 33 missing values ) , homelessness ( 46 missing values ) , illiteracy ( 4 missing values ) , and marital status ( 6 missing values ) .", "label": "", "metadata": {}, "score": "93.57787"}
{"text": "Alvarez - Uria G , Midde M , Naik PK .Trends and risk factors for HIV infection among young pregnant women in rural India .", "label": "", "metadata": {}, "score": "93.78722"}
{"text": "This is an open - access article distributed under the terms of the Creative Commons Attribution - NonCommercial - NoDerivitives 3.0 License , where it is permissible to download and share the work provided it is properly cited .", "label": "", "metadata": {}, "score": "93.80623"}
{"text": "But as with human musicians , even the best are not machines .A biomedical breakthrough published today in the journal Nature reveals never - before - seen details of the human body 's cellular switchboard that regulates sensory and hormonal responses .", "label": "", "metadata": {}, "score": "93.83588"}
{"text": "Lancet 2008 ; 371 : 1443 - 51 .[PubMed ] .Koenig SP , Leandre F , Farmer PE .Scaling - up HIV treatment programmes in resource - limited settings : the rural Haiti experience .", "label": "", "metadata": {}, "score": "93.839615"}
{"text": "Once enrolled , they will return to the clinic to be seen by study staff at one month , four months and then every four months thereafter .", "label": "", "metadata": {}, "score": "94.32692"}
{"text": "Here is a small selection from the many studies from clinical practice that have shown HAART substantially reduces death and illness .Besides the studies shown here , HAART has been shown to reduce death and illness in Zambia , Hong Kong and Brazil .", "label": "", "metadata": {}, "score": "94.36517"}
{"text": "The UK CHIC Study is funded by the Medical Research Council , UK ( Grant numbers G0000199 , G0600337 and G0900274 ) .The views expressed in this manuscript are those of the researchers and not necessarily those of the MRC .", "label": "", "metadata": {}, "score": "95.00699"}
{"text": "Cox proportional hazard models compared risk of ART discontinuation .Results : Nine thousand , four hundred and six individuals were included : median age 37 years , 61 % white , 80 % men , median viral load 4.8 log copies / ml .", "label": "", "metadata": {}, "score": "95.118164"}
{"text": "General Disclaimer : The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services .The information provided through The Body should not be used for diagnosing or treating a health problem or a disease .", "label": "", "metadata": {}, "score": "95.3143"}
{"text": "D.C. has received fees from BMS , Viiv and Gilead in connection with conference attendance and preparation of educational materials .R.G. has received funding from BMS , Gilead , Pfizer , Janssen , Roche and Merck in connection with project grants , conference attendance , speakers fees and membership of advisory boards .", "label": "", "metadata": {}, "score": "95.49424"}
{"text": "Lancet 2002 ; 360 : 119 - 29 .[PubMed ] .Lundgren JD , Babiker A , El - Sadr W , Emery S , Grund B , Neaton JD , et al .", "label": "", "metadata": {}, "score": "95.86153"}
{"text": "The countries of southern Africa are the areas of the world hit hardest by the TB and HIV epidemics and the absolute TB rates recorded are likely to be higher than those in other regions .", "label": "", "metadata": {}, "score": "96.13507"}
{"text": "C.A.S. and S.F. designed the study and were involved in analysis and preparation of the manuscript .K.Q. was involved in discussions around study design and analysis and helped prepare the manuscript .", "label": "", "metadata": {}, "score": "96.535126"}
{"text": "The UK Collaborative HIV Cohort ( CHIC )Study is an observational study collecting data from many of the UK 's largest HIV treatment centres [ 14 ] .", "label": "", "metadata": {}, "score": "96.561905"}
{"text": "EuroSIDA Study Group JD .Am J Respir Crit Care Med 2000 ; 162:865 - 872 .Girardi E , Antonucci G , Vanacore P , Libanore M , Errante I , Matteelli A , et al .", "label": "", "metadata": {}, "score": "96.82004"}
{"text": "Acknowledgements .S.D.L. is funded by the Wellcome Trust , London , UK with grant number 074641 .R.W. , L.M. and L.G.B. are funded in part by the National Institutes of Health through a CIPRA grant 1U19AI53217 - 01 and R.W. also receives support from RO1 grant ( A1058736 - 01A1 ) .", "label": "", "metadata": {}, "score": "96.88964"}
{"text": "Cited By : .This article has been cited 27 time(s ) .10.1093/infdis / jis693 CrossRef .ARTN e67177 CrossRef .ARTN e50923 CrossRef .", "label": "", "metadata": {}, "score": "96.97751"}
{"text": "Poisson regression models comparing number of events , in study monitoring efficacy of ART , Tororo and Busia Districts , Uganda , 2003 - 2007 .", "label": "", "metadata": {}, "score": "97.01197"}
{"text": "The overall attrition rate was 14.1 per 100 PY , the mortality rate was 7 per 100 PY , and the LTFU rate was 7.1 per 100 PY .", "label": "", "metadata": {}, "score": "97.47485"}
{"text": "The \" thought - to - speech \" process ... .We know that characters in novels and movies are fictitious , and we also understand that historical figures - even if we 've never ...", "label": "", "metadata": {}, "score": "97.4884"}
{"text": "Study population .The ART service in Gugulethu township in Cape Town has been described previously [ 21,22 ] .The district has a predominantly African population of over 300 000 , the vast majority of whom live in conditions of low socioeconomic status .", "label": "", "metadata": {}, "score": "97.73556"}
{"text": "[ PMC free article ] [ PubMed ] .Hosseinipour MC , van Oosterhout JJ , Weigel R , Phiri S , Kamwendo D , Parkin N , et al .", "label": "", "metadata": {}, "score": "98.01094"}
{"text": "ARTN e10527 CrossRef .What does \" Remember me \" mean ?By checking this box , you 'll stay logged in until you logout .", "label": "", "metadata": {}, "score": "98.13089"}
{"text": "UK Collaborative HIC Cohort Steering Committee The creation of a large UK - based multicentre cohort of HIV - infected individuals : The UK Collaborative HIV Cohort ( UK CHIC )", "label": "", "metadata": {}, "score": "98.16022"}
{"text": "What if I 'm on a computer that I share with others ?If you 're using a public computer or you share this computer with others , we recommend that you uncheck the \" Remember me \" box .", "label": "", "metadata": {}, "score": "98.94717"}
{"text": "What if I 'm on a computer that I share with others ?If you 're using a public computer or you share this computer with others , we recommend that you uncheck the \" Remember me \" box .", "label": "", "metadata": {}, "score": "98.94717"}
{"text": "What if I 'm on a computer that I share with others ?If you 're using a public computer or you share this computer with others , we recommend that you uncheck the \" Remember me \" box .", "label": "", "metadata": {}, "score": "98.94717"}
{"text": "Received : 12 June 2013 ; Revised : 22 August 2013 ; Accepted : 23 August 2013 ; Published : 12 September 2013 .Global Health Action 2013 .", "label": "", "metadata": {}, "score": "99.08678"}
{"text": "30 That review included five reports with follow - up times of 36 months or more and the proportion of participants with virological success varied from 58 % to 98 % .", "label": "", "metadata": {}, "score": "99.203064"}
{"text": "What does \" Remember me \" mean ?By checking this box , you 'll stay logged in until you logout .You 'll get easier access to your articles , collections , media , and all your other content , even if you close your browser or shut down your computer .", "label": "", "metadata": {}, "score": "100.77153"}
{"text": "What does \" Remember me \" mean ?By checking this box , you 'll stay logged in until you logout .You 'll get easier access to your articles , collections , media , and all your other content , even if you close your browser or shut down your computer .", "label": "", "metadata": {}, "score": "100.77153"}
{"text": "Diagnoses of Kaposi 's sarcoma and cervical cancer were based on biopsy results .Pneumocystis jirovecii pneumonia was diagnosed clinically with chest radiography , clinical presentation , and a response to cotrimoxazole treatment .", "label": "", "metadata": {}, "score": "100.772736"}
{"text": "Towns have better communications than rural areas .Poverty was defined as living with less than 1,000 Indian rupees per month ( approximately US$ 18 as of May 2013 ) .", "label": "", "metadata": {}, "score": "100.84748"}
{"text": "Golub JE , Saraceni V , Cavalcante SC , Pacheco AG , Moulton LH , King BS , et al .The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV - infected patients in Rio de Janeiro , Brazil .", "label": "", "metadata": {}, "score": "101.17624"}
{"text": "Scheduled castes and scheduled tribes are considered socially disadvantaged communities and are supported by positive discrimination schemes operated by the Government of India ( 17 ) .", "label": "", "metadata": {}, "score": "101.48534"}
{"text": "Forty - one percent of patients were women , two thirds were married , and the median age was 33.8 years [ interquartile range ( IQR ) 28 - 40].", "label": "", "metadata": {}, "score": "101.79785"}
{"text": "Geneva : WHO ; 2007 .Meintjes G , Lawn SD , Scano F , Maartens G , French MA , Worodria W , et al .", "label": "", "metadata": {}, "score": "101.888626"}
{"text": "Analyses were performed using SAS , version 9.1 ( SAS Institute Inc. , Cary , North Carolina , USA ) .Results .Baseline characteristics .", "label": "", "metadata": {}, "score": "102.16118"}
{"text": "Cox proportional hazard models comparing time to first serious morbidity or death , in study monitoring efficacy of ART , Tororo and Busia Districts , Uganda , 2003 - 7 .", "label": "", "metadata": {}, "score": "102.25533"}
{"text": "Acknowledgements .P.T. was the primary writer of the manuscript and led the analysis .M.K. was the analyst / statistician .She reviewed and edited the manuscript .", "label": "", "metadata": {}, "score": "102.355896"}
{"text": "Figure 4 presents the Cox regression analysis of factors associated with attrition , mortality , and LTFU .Female gender ( aHR 0.64 , 95 % CI 0.55 - 0.76 ) and poverty ( aHR 0.86 , 95 % CI 0.75 - 0.99 ) were factors associated with a lower risk of attrition .", "label": "", "metadata": {}, "score": "102.985374"}
{"text": "The MTCT - Plus Initiative provided support to clinical programs in Cameroon , Cote d'Ivoire , Kenya , Mozambique , Rwanda , South Africa , Uganda , Zambia , and Thailand to implement HIV / AIDS care and treatment to families identified through perinatal HIV prevention services [ 33,34 ] .", "label": "", "metadata": {}, "score": "103.23474"}
{"text": "Gang IN , Sen K , Yun MS .Caste , ethnicity , and poverty in rural India .Bonn , Germany : IZA ; 2002 .", "label": "", "metadata": {}, "score": "103.37068"}
{"text": "WW supervised study implementation .JPE and RD performed statistical analyses .FK supported study development , coordination , and data interpretation .RD supervised laboratory testing .", "label": "", "metadata": {}, "score": "103.88806"}
{"text": "Read more \" . ... cells per CUBIC MILLIMETER of blood ( a cubic millimeter is a very small amount , roughly one small drop ) .", "label": "", "metadata": {}, "score": "106.0344"}
{"text": "It felt like my mind was trying to escape from my body to run away from this .Even ...Read more \" .The Body is a service of Remedy Health Media , LLC , 750 3rd Avenue , 6th Floor , New York , NY 10017 .", "label": "", "metadata": {}, "score": "106.04353"}
{"text": "For more information , please refer to our Privacy Policy .Author Information . a International Center for AIDS Care and Treatment Programs ( ICAP ) , Columbia University Mailman School of Public Health , New York , New York , USA .", "label": "", "metadata": {}, "score": "106.22475"}
{"text": "The Vicente Ferrer HIV Cohort Study is an open cohort study of all HIV infected patients who have attended RDT hospitals since June 2006 .Routine clinical data from patients were collected prospectively since September 2009 , and retrospectively from June 2006 to September 2009 .", "label": "", "metadata": {}, "score": "106.54891"}
{"text": "Conclusions and policy implications .Notes .We thank Tororo Hospital staff ; the staff and clients of the AIDS Support Organisation ; the US Embassy in Kampala ; Global AIDS Program headquarters ; and staff of CDC - Uganda , especially the informatics , clinical , laboratory , and administrative units of CDC - Tororo .", "label": "", "metadata": {}, "score": "106.62128"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "106.78023"}
{"text": "For the 244 women who remained in the program 24 weeks or more , 80 % gained at least 50 cells / \u03bcl and 41.4 % gained 100 - 250 cells / \u03bcl [ 30 ] .", "label": "", "metadata": {}, "score": "106.93996"}
{"text": "Wolters Kluwer Health may email you for journal alerts and information , but is committed to maintaining your privacy and will not share your personal information without your express consent .", "label": "", "metadata": {}, "score": "107.37778"}
{"text": "Wolters Kluwer Health may email you for journal alerts and information , but is committed to maintaining your privacy and will not share your personal information without your express consent .", "label": "", "metadata": {}, "score": "107.37778"}
{"text": "c Infectious Diseases Epidemiology Unit , School of Public Health and Family Medicine , Faculty of Health Sciences , University of Cape Town , Cape Town , South Africa .", "label": "", "metadata": {}, "score": "107.61354"}
{"text": "Received 11 May , 2009 .Correspondence to Patricia L. Toro , MD , MPH , 722 West 168th Street , International Center for AIDS Care and Treatment Programs ( ICAP ) , Columbia University Mailman School of Public Health , New York , NY 10032 , USA .", "label": "", "metadata": {}, "score": "109.8587"}
{"text": "b School of Health Sciences , City University London , UK .Correspondence to Clare E. French , BSc , MSc , Population , Policy and Practice Programme , UCL Institute of Child Health , 30 Guilford St , London WC1N 1EH , UK .", "label": "", "metadata": {}, "score": "112.552284"}
{"text": "Correspondence to Miss Sophie Jose , Research Department of Infection and Population Health , UCL , Royal Free Campus , Rowland Hill Street , London NW3 2PF , UK .", "label": "", "metadata": {}, "score": "114.725876"}
{"text": "The Body is a service of Remedy Health Media , LLC , 750 3rd Avenue , 6th Floor , New York , NY 10017 .The Body and its logos are trademarks of Remedy Health Media , LLC , and its subsidiaries , which owns the copyright of The Body 's homepage , topic pages , page designs and HTML code .", "label": "", "metadata": {}, "score": "115.34412"}
{"text": "If you 're using a public computer or you share this computer with others , we recommend that you uncheck the \" Remember me \" box .", "label": "", "metadata": {}, "score": "115.66704"}
{"text": "As a scientist involved in the Concorde trial explained in an affidavit rebutting AIDS denialist Anthony Brink in a South African court case which Brink pulled out of , Concorde was not testing whether AZT was better than placebo ; this was already known .", "label": "", "metadata": {}, "score": "116.65853"}
{"text": "Clare French was funded by a Medical Research Council PhD studentship .Shema Tariq was funded by a Medical Research Council Research Training Fellowship .References .", "label": "", "metadata": {}, "score": "118.90554"}
{"text": "Received 28 January , 2009 .Correspondence to Stephen D. Lawn , Desmond Tutu HIV Centre , Institute of Infectious Disease and Molecular Medicine , Faculty of Health Sciences , University of Cape Town , Anzio Road , Observatory 7925 , Cape Town , South Africa .", "label": "", "metadata": {}, "score": "121.34573"}
